Although	O
glutamine	other-biologything
is	O
metabolized	O
to	O
glutamate	other-biologything
and	O
ammonia	other-biologything
,	O
both	O
of	O
which	O
have	O
neurological	O
effects	O
,	O
their	O
concentrations	O
are	O
not	O
increased	O
much	O
,	O
and	O
no	O
adverse	O
neurological	O
effects	O
were	O
detected	O
.	O

The	O
physician	O
will	O
provide	O
you	O
a	O
course	O
of	O
2	O
weeks	O
of	O
antibiotics	O
to	O
eliminate	O
any	O
possible	O
bacterial	O
overgrowth	O
and	O
repeat	O
the	O
test	O
to	O
check	O
whether	O
radio-labeled	O
Vitamin	other-biologything
B12	other-biologything
would	O
be	O
found	O
in	O
urine	O
or	O
not	O
.	O

Phosphatidylinositol	other-biologything
binding	other-biologything
clathrin	other-biologything
assembly	other-biologything
protein	other-biologything
,	O
also	O
known	O
as	O
PICALM	other-biologything
,	O
is	O
a	O
protein	O
which	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
PICALM	other-biologything
``	O
gene	O
.	O

She	O
is	O
currently	O
a	O
tenured	O
faculty	O
in	O
the	O
Department	O
of	O
Medicine	O
and	O
Biochemistry	other-biologything
at	O
the	O
University	O
of	O
Ottawa	O
.	O

IL-2	other-biologything
promotes	O
either	O
immunity	O
or	O
tolerance	O
in	O
a	O
concentration	O
dependent	O
fashion	O
by	O
acting	O
on	O
T	O
helper	O
cells	O
,	O
CTL	other-biologything
and	O
NK	other-biologything
cells	O
.	O

Where	O
they	O
occur	O
in	O
plants	O
,	O
they	O
sometimes	O
coexist	O
with	O
anthoxanthins	other-biologything
(	O
yellow	O
to	O
orange	O
flavonoids	other-biologything
)	O
,	O
but	O
never	O
occur	O
in	O
plant	O
species	O
with	O
anthocyanins	other-biologything
.	O

Under	O
non-dividing	O
conditions	O
(	O
when	O
the	O
cell	O
is	O
in	O
the	O
G0	other-biologything
phase	other-biologything
of	O
the	O
cell	O
cycle	O
)	O
,	O
Retinoblastoma	other-biologything
protein	other-biologything
(	O
Rb	other-biologything
)	O
is	O
bound	O
with	O
the	O
E2F	other-biologything
transcription	O
factor	O
.	O

Proteases	O
capable	O
of	O
degrading	O
aggrecans	O
are	O
called	O
aggrecanases	other-biologything
,	O
and	O
they	O
are	O
members	O
of	O
the	O
ADAM	other-biologything
(	O
A	O
Disintegrin	O
And	O
Metalloprotease	O
)	O
protein	O
family	O
.	O

Patient	O
's	O
with	O
mutations	O
in	O
``	O
ATP6V1B1	other-biologything
``	O
and	O
``	O
ATP6V0A4	other-biologything
``	O
will	O
present	O
with	O
symptoms	O
within	O
the	O
first	O
year	O
of	O
life	O
,	O
while	O
those	O
with	O
mutation	O
of	O
the	O
``	O
SLC4A1	other-biologything
``	O
have	O
delayed	O
onset	O
around	O
10	O
years	O
of	O
age	O
.	O

Botox	other-biologything
injections	O
result	O
in	O
more	O
generalized	O
relief	O
of	O
tics	O
than	O
the	O
vocal	O
relief	O
expected	O
.	O

P53	other-biologything
regulation	O
associated	O
lncRNA	other-biologything
is	O
a	O
protein	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
PRAL	other-biologything
gene	other-biologything
.	O

Like	O
the	O
histones	other-biologything
,	O
HMGB1	other-biologything
is	O
among	O
the	O
most	O
important	O
chromatin	other-biologything
proteins	other-biologything
.	O

The	O
main	O
amino	O
acid	O
residues	O
forming	O
the	O
active	O
site	O
are	O
Tyr	other-biologything
105	other-biologything
,	O
Trp	other-biologything
149	other-biologything
,	O
Val	other-biologything
167	other-biologything
,	O
Met	other-biologything
180	other-biologything
,	O
Val	other-biologything
208	other-biologything
,	O
Phe	other-biologything
226	other-biologything
,	O
Ser	other-biologything
269	other-biologything
,	O
Met	other-biologything
276	other-biologything
,	O
His	other-biologything
277	other-biologything
,	O
His	other-biologything
307	other-biologything
,	O
Phe	other-biologything
308	other-biologything
,	O
Glu	other-biologything
309	other-biologything
,	O
Leu	other-biologything
323	other-biologything
,	O
and	O
Phe	other-biologything
324	other-biologything
.	O

It	O
is	O
known	O
as	O
the	O
delta	O
subunit	O
in	O
mitochondrial	other-biologything
ATP	other-biologything
syntheses	other-biologything
,	O
and	O
the	O
epsilon	other-biologything
subunit	other-biologything
in	O
bacterial	O
and	O
c	O
hloroplastic	other-biologything
ATP	other-biologything
syntheses	other-biologything
.	O

The	O
IFNγ	other-biologything
receptor	O
is	O
expressed	O
on	O
the	O
macrophages	other-biologything
and	O
other	O
cells	O
and	O
consists	O
of	O
IFNγR1	other-biologything
and	O
IFNγR2	other-biologything
subunits	O
.	O

LentiGlobin	other-biologything
BB305	other-biologything
is	O
a	O
lentiviral	O
vector	O
which	O
inserts	O
a	O
functioning	O
version	O
of	O
the	O
HBB	other-biologything
gene	other-biologything
into	O
a	O
patient	O
's	O
blood-producing	O
hematopoietic	other-biologything
stem	other-biologything
cells	other-biologything
(	O
HSC	other-biologything
)	O
ex	O
vivo	O
.	O

MDM2	other-biologything
is	O
also	O
required	O
for	O
organ	O
development	O
and	O
tissue	O
homeostasis	O
because	O
unopposed	O
p53	other-biologything
activation	O
leads	O
to	O
p53-overactivation-dependent	other-biologything
cell	other-biologything
death	O
,	O
referred	O
to	O
as	O
podoptosis	O
.	O

Leucine	other-biologything
rich	O
repeat	O
containing	O
3	O
is	O
a	O
protein	other-biologything
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
LRRC3	other-biologything
gene	other-biologything
.	O

Curds	O
form	O
,	O
however	O
,	O
due	O
to	O
the	O
function	O
that	O
the	O
enzyme	O
,	O
rennet	other-biologything
,	O
plays	O
in	O
removing	O
the	O
hairy	O
layer	O
in	O
the	O
casein	other-biologything
micelle	O
.	O

Carcinoembryonic	other-biologything
antigen	other-biologything
(	O
CEA	other-biologything
)	O
describes	O
a	O
set	O
of	O
highly	O
related	O
glycoproteins	O
involved	O
in	O
cell	O
adhesion	O
.	O

Crc	other-biologything
-mediated	O
regulation	O
impact	O
processes	O
such	O
as	O
biofilm	O
formation	O
,	O
virulence	O
and	O
antibiotic	O
susceptibility	O
.	O

Another	O
example	O
of	O
the	O
structural	O
similarity	O
of	O
some	O
inhibitors	O
to	O
the	O
substrates	O
of	O
the	O
enzymes	other-biologything
they	O
target	O
is	O
seen	O
in	O
the	O
figure	O
comparing	O
the	O
drug	O
methotrexate	other-biologything
to	O
folic	other-biologything
acid	other-biologything
.	O

Treatment	O
with	O
a	O
murine	O
analog	O
of	O
solanezumab	other-biologything
(	O
m266	other-biologything
)	O
lead	O
to	O
an	O
increase	O
in	O
plasma	other-biologything
amyloid	other-biologything
beta	other-biologything
,	O
which	O
was	O
all	O
bound	O
to	O
m266	other-biologything
.	O

Levels	O
of	O
DHEA-S	other-biologything
in	O
circulation	O
are	O
approximately	O
250	O
to	O
300	O
times	O
those	O
of	O
DHEA	other-biologything
.	O

This	O
ligation	O
of	O
the	O
thiolate	O
to	O
the	O
iron	O
center	O
anchors	O
the	other-biologything
ACV	other-biologything
within	O
the	O
active	O
site	O
.	O

At	O
the	O
CH	other-biologything
domain	O
calponin	O
binds	O
to	O
α-actin	other-biologything
and	O
filamin	other-biologything
and	O
binds	other-biologything
to	O
actin	O
within	O
the	O
RD	other-biologything
domain	O
.	O

Expression	O
of	O
c-Fos	other-biologything
in	O
the	O
following	O
areas	O
has	O
been	O
observed	O
:	O

Many	O
cells	O
synthesize	O
TGF-β	other-biologything
and	O
almost	O
all	O
of	O
them	O
have	O
specific	O
receptors	O
for	O
this	O
peptide	O
.	O

Overexpression	O
of	O
the	O
enzymes	O
in	O
the	O
valine	O
biosynthetic	O
pathway	O
of	O
``	O
S.	other-biologything
cerevisiae	other-biologything
``	O
has	O
been	O
used	O
to	O
improve	O
isobutanol	O
yields	O
.	O

There	O
is	O
a	O
general	O
consensus	O
that	O
sorbic	other-biologything
acid	other-biologything
and	O
sorbates	other-biologything
are	O
intrinsically	O
devoid	O
of	O
carcinogenic	O
activity	O
.	O

In	O
addition	O
,	O
Akt	other-biologything
phosphorylates	O
Thr145	other-biologything
and	O
Ser146	other-biologything
of	O
p21Cip1	other-biologything
,	O
preventing	O
PCNA	other-biologything
binding	O
and	O
decreasing	O
stability	O
.	O

Degradation	O
of	O
the	O
neurotransmitters	O
,	O
dopamine	other-biologything
and	O
noradrenaline	other-biologything
,	O
is	O
approximately	O
4-fold	O
greater	O
when	O
the	O
amino	O
acid	O
presented	O
is	O
valine	other-biologything
instead	O
of	O
methionine	other-biologything
.	O

Protein	other-biologything
A	other-biologything
attaches	O
to	O
the	O
Fc	O
region	O
of	O
host	O
antibodies	other-biologything
,	O
rendering	O
them	O
useless	O
.	O

The	O
laminin	other-biologything
B	other-biologything
domain	other-biologything
(	O
also	O
known	O
as	O
domain	other-biologything
IV	other-biologything
)	O
is	O
an	O
extracellular	O
module	O
of	O
unknown	O
function	O
.	O

The	O
buildup	O
of	O
GAGs	other-biologything
in	O
different	O
parts	O
of	O
the	O
body	O
causes	O
symptoms	O
in	O
many	O
different	O
organ	O
systems	O
.	O

Glutamine	other-biologything
is	O
synthesized	O
by	O
the	O
enzyme	other-biologything
glutamine	other-biologything
synthetase	O
from	O
glutamate	other-biologything
and	O
ammonia	other-biologything
.	O

Embryological	other-biologything
mesenchymal	other-biologything
cells	other-biologything
expresses	O
fibroblast-specific	other-biologything
protein	other-biologything
(	O
Fsp1	other-biologything
)	O
,	O
which	O
is	O
indicative	O
of	O
their	O
shared	O
properties	O
with	O
the	O
migratory	O
adult	O
fibroblasts	O
,	O
and	O
c-Fos	other-biologything
,	O
an	O
oncogene	other-biologything
associated	O
with	O
the	O
down-regulation	O
of	O
epithelial	other-biologything
cadherin	other-biologything
.	O
&	O
lt	O
;	O
ref	O
name=	O
''	O
Epithelial	other-biologything
mesenchymal	other-biologything
transition	O
by	O
c-Fos	other-biologything
estrogen	O
receptor	O
activation	O
involves	O
nuclear	O
translocation	O
of	O
beta-catenin	other-biologything
and	O
upregulation	O
of	O
beta-catenin	other-biologything
/	O
lymphoid	other-biologything
enhancer	other-biologything
binding	other-biologything
factor-1	other-biologything
transcriptional	O
activity	O
.	O

PTCH1	O
has	O
a	O
sterol	O
sensing	O
domain	O
(	O
SSD	O
)	O
,	O
which	O
has	O
been	O
shown	O
to	O
be	O
essential	O
for	O
suppression	O
of	O
SMO	other-biologything
activity	O
.	O

This	O
happens	O
because	O
``	O
C.	other-biologything
botulinum	other-biologything
``	O
produces	O
a	O
toxin	O
which	O
blocks	O
the	O
release	O
of	O
acetylcholine	other-biologything
.	O

In	O
particular	O
,	O
CDO	other-biologything
responds	O
to	O
changes	O
in	O
dietary	O
cysteine	other-biologything
availability	O
and	O
protein	O
intake	O
,	O
maintaining	O
decreased	O
activity	O
with	O
low	O
cysteine	other-biologything
levels	O
and	O
increased	O
activity	O
at	O
high	O
levels	O
to	O
prevent	O
cytotoxicity	O
.	O

Rho	other-biologything
factor	other-biologything
binds	O
to	O
the	O
transcription	O
terminator	O
pause	O
site	O
,	O
an	O
exposed	O
region	O
of	O
single	O
stranded	O
RNA	other-biologything
(	O
a	O
stretch	O
of	O
72	other-biologything
nucleotides	other-biologything
)	O
after	O
the	O
open	O
reading	O
frame	O
at	O
C-rich/G	other-biologything
-poor	O
sequences	O
that	O
lack	O
obvious	O
secondary	O
structure	O
.	O

Activation	O
of	O
NMDA	other-biologything
receptors	O
causes	O
dissociation	O
of	O
DISC1	other-biologything
and	O
kal-7	other-biologything
,	O
leaving	O
kal-7	other-biologything
available	O
to	O
activate	O
rac1	other-biologything
.	O

Usually	O
,	O
in	O
the	O
presence	O
of	O
NADPH	other-biologything
dehydrogenase	other-biologything
or	O
NADH	other-biologything
dehydrogenase	other-biologything
as	O
the	O
enzyme	O
,	O
NADPH	other-biologything
or	O
NADH	other-biologything
is	O
the	O
reductant	O
that	O
converts	O
resazurin	other-biologything
to	O
resorufin	other-biologything
.	O

In	O
all	O
neurons	other-biologything
,	O
ELAVL3	other-biologything
is	O
expressed	O
,	O
and	O
in	O
pyramidal	O
neurons	other-biologything
,	O
NRGN	other-biologything
and	O
REEP2	other-biologything
are	O
also	O
expressed	O
.	O

ADAM7	other-biologything
is	O
also	O
denoted	O
as	O
:	O
ADAM_7	other-biologything
,	O
ADAM-7	other-biologything
,	O
EAPI	other-biologything
,	O
GP-83	other-biologything
,	O
and	O
GP83	other-biologything
.	O

Amantadine	other-biologything
,	O
a	O
tricyclic	O
symmetric	O
amine	O
,	O
is	O
a	O
proven	O
suppressor	O
that	O
specifically	O
inhibits	O
the	O
HAV	other-biologything
IRES	other-biologything
dependent	O
translation	O
of	O
HAV	other-biologything
RNA	O
.	O

p53	other-biologything
mutations	O
can	O
result	O
in	O
a	O
significant	O
checkpoint	O
deficit	O
,	O
which	O
has	O
important	O
implications	O
in	O
the	O
treatment	O
of	O
cancer	O
.	O

The	O
trail	O
continues	O
along	O
the	O
Elwha	O
River	O
through	O
a	O
riparian	O
forest	O
of	O
bigleaf	O
maple	O
,	O
red	O
alder	O
,	O
black	O
cottonwood	O
,	O
with	O
Douglas	other-biologything
fir	other-biologything
,	O
Western	other-biologything
red	other-biologything
cedar	other-biologything
,	O
and	O
Grand	other-biologything
fir	other-biologything
.	O

The	O
AP-1	other-biologything
complex	O
has	O
been	O
implicated	O
in	O
transformation	O
and	O
progression	O
of	O
cancer	O
.	O

Phosphatidylinositol	other-biologything
4,5-bisphosphate	other-biologything
5-phosphatase	other-biologything
A	other-biologything
is	O
an	O
enzyme	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	other-biologything
INPP5J	other-biologything
''	other-biologything
gene	other-biologything
.	O

Botulinum	other-biologything
toxin	other-biologything
produced	O
by	O
the	O
bacteria	O
Clostridium	other-biologything
botulinum	other-biologything
is	O
the	O
most	O
powerful	O
toxic	O
protein	other-biologything
.	O

Of	O
these	O
,	O
HER2/neu	other-biologything
(	O
also	O
known	O
as	O
Erb-B2	other-biologything
)	O
was	O
the	O
first	O
to	O
be	O
developed	O
.	O

``	O
Sulfolobus	other-biologything
islandicus	other-biologything
``	O
also	O
uses	O
a	O
Cdt1	other-biologything
homologue	O
to	O
recognize	O
one	O
of	O
its	O
replication	O
origins	O
.	O

By	O
modulating	O
retinoblastoma	O
protein	O
activity	O
in	O
rat	other-biologything
cochlea	other-biologything
,	O
sonic	other-biologything
hedgehog	other-biologything
allows	O
mature	O
hair	O
cells	O
that	O
normally	O
can	O
not	O
return	O
to	O
a	O
proliferative	O
state	O
to	O
divide	O
and	O
differentiate	O
.	O

First	O
,	O
one	O
HBB	other-biologything
and	O
one	O
HBA1	other-biologything
combine	O
,	O
non-covalently	O
,	O
to	O
form	O
a	O
dimer	other-biologything
.	O

The	O
p53	other-biologything
protein	other-biologything
functions	O
as	O
a	O
transcription	O
factor	O
with	O
a	O
crucial	O
role	O
in	O
orchestrating	O
the	O
cellular	O
stress	O
response	O
.	O

It	O
can	O
be	O
found	O
in	O
``	O
Rhodopseudomonas	other-biologything
palustris	other-biologything
``	O
.	O

Hsp27	other-biologything
is	O
also	O
involved	O
in	O
the	O
apoptotic	O
signalling	O
pathway	O
.	O

It	O
is	O
the	O
initial	O
and	O
rate-limiting	O
step	O
in	O
pyrimidine	other-biologything
catabolism	other-biologything
.	O

Serine	O
protease	O
inhibitor	O
Kazal-type	other-biologything
2	other-biologything
also	O
known	O
as	O
acrosin-trypsin	O
inhibitor	O
is	O
a	O
protein	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
SPINK2	other-biologything
``	O
gene	O
.	O

A	O
rapid	O
and	O
selective	O
degradation	O
of	O
calponin	other-biologything
2	other-biologything
occurs	O
in	O
lung	O
tissues	O
after	O
a	O
short	O
period	O
of	O
deflation	O
.	O

At	O
least	O
17	O
DNA	other-biologything
repair	O
proteins	O
,	O
distributed	O
among	O
five	O
DNA	other-biologything
repair	O
pathways	O
,	O
have	O
a	O
``	O
dual	O
role	O
''	O
in	O
response	O
to	O
DNA	other-biologything
damage	O
.	O

As	O
cenderitide	other-biologything
interacts	O
with	O
both	O
NRP-A	other-biologything
and	O
NRP-B	other-biologything
,	O
this	O
drug	O
has	O
antifibrotic	O
potential	O
.	O

Fibrin	other-biologything
consists	O
of	O
the	O
blood	other-biologything
proteins	other-biologything
fibrinogen	other-biologything
and	O
thrombin	other-biologything
which	O
participate	O
in	O
blood	O
clotting	O
.	O

The	O
tumor	O
suppressor	O
gene	O
p53	other-biologything
regulates	O
DNA	other-biologything
repair	O
and	O
can	O
induce	O
apoptosis	O
in	O
dysregulated	O
cells	O
.	O

The	O
symmetrical	O
binding	O
takes	O
place	O
along	O
the	O
NT-3	other-biologything
interfaces	O
,	O
resulting	O
in	O
a	O
2:2	O
ligand-receptor	O
cluster	O
in	O
the	O
center	O
.	O

Alanine	other-biologything
is	O
one	O
of	O
the	O
twenty	O
canonical	O
α-amino	O
acids	O
used	O
as	O
building	O
blocks	O
(	O
monomers	O
)	O
for	O
the	O
ribosome-mediated	O
biosynthesis	O
of	O
proteins	O
.	O

The	O
chemical	O
phosphorus	other-biologything
removal	O
in	O
those	O
systems	O
may	O
be	O
used	O
as	O
a	O
backup	O
system	O
,	O
for	O
use	O
when	O
the	O
biological	O
phosphorus	other-biologything
removal	O
is	O
not	O
removing	O
enough	O
phosphorus	other-biologything
,	O
or	O
may	O
be	O
used	O
continuously	O
.	O

Mitogen-activated	other-biologything
protein	other-biologything
kinase	other-biologything
kinase	other-biologything
kinase	other-biologything
2	other-biologything
is	O
an	O
enzyme	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
MAP3K2	other-biologything
``	O
gene	O
.	O

TGF-β	other-biologything
is	O
pleiotropic	O
and	O
multifunctional	O
,	O
meaning	O
they	O
are	O
able	O
to	O
act	O
on	O
a	O
wide	O
variety	O
of	O
cell	O
types	O
.	O

Clathrin	other-biologything
coats	other-biologything
contain	O
both	O
clathrin	other-biologything
(	O
acts	O
as	O
a	O
scaffold	O
)	O
and	O
adaptor	other-biologything
complexes	other-biologything
that	O
link	O
clathrin	other-biologything
to	O
receptors	O
in	O
coated	O
vesicles	O
.	O

Proteins	O
containing	O
this	O
residue	O
are	O
found	O
at	O
the	O
active	O
site	O
of	O
some	O
nitrile	other-biologything
hydratases	other-biologything
.	O

USP42	other-biologything
has	O
also	O
been	O
shown	O
to	O
deubiquitinate	O
p53	other-biologything
and	O
may	O
be	O
required	O
for	O
the	O
ability	O
of	O
p53	other-biologything
to	O
respond	O
to	O
stress	O
.	O

Llama	other-biologything
,	O
alpaca	other-biologything
and	O
vicuña	other-biologything
were	O
also	O
domesticated	O
and	O
used	O
for	O
transport	O
,	O
food	O
and	O
clothing	O
.	O

where	O
they	O
inserted	O
NiFe	other-biologything
hydrogenase	other-biologything
into	O
polypyrrole	O
films	O
and	O
to	O
provide	O
proper	O
contact	O
to	O
the	O
electrode	O
,	O
there	O
were	O
redox	O
mediators	O
entrapped	O
into	O
the	O
film	O
.	O

Skatole	other-biologything
is	O
derived	O
from	O
the	O
amino	other-biologything
acid	other-biologything
tryptophan	other-biologything
in	O
the	O
digestive	O
tract	O
of	O
mammals	O
.	O

It	O
is	O
associated	O
with	O
the	O
signalling	O
pathway	O
of	O
JAK1	other-biologything
and	O
JAK2	other-biologything
,	O
leading	O
to	O
the	O
homodimerization	O
of	O
STAT1	other-biologything
molecule	O
.	O

Most	O
plant	O
R	other-biologything
genes	other-biologything
encode	O
NOD	other-biologything
-like	O
receptor	O
(	O
NLR	other-biologything
)	O
proteins	O
.	O

Other	O
names	O
in	O
common	O
use	O
include	O
threonine	other-biologything
synthetase	other-biologything
,	O
and	O
O-phospho-L-homoserine	other-biologything
phospho-lyase	other-biologything
(	other-biologything
adding	other-biologything
water	other-biologything
)	other-biologything
.	O

In	O
the	O
normal	O
pathway	O
,	O
factor	other-biologything
V	other-biologything
functions	O
as	O
a	O
cofactor	O
to	O
allow	O
factor	other-biologything
Xa	other-biologything
to	O
activate	O
prothrombin	other-biologything
,	O
resulting	O
in	O
the	O
enzyme	other-biologything
thrombin	other-biologything
.	O

A	O
genetic	O
approach	O
involving	O
intrabodies	O
that	O
block	O
CCR5	other-biologything
expression	O
has	O
been	O
proposed	O
as	O
a	O
treatment	O
for	O
HIV-1	other-biologything
infected	O
individuals	O
.	O

A	O
dual	O
role	O
of	O
EFS	other-biologything
in	O
mature	O
T	other-biologything
cells	other-biologything
function	O
has	O
been	O
proposed	O
because	O
both	O
overexpression	O
and	O
siRNA	O
knockdown	O
of	O
this	O
protein	O
in	O
cell	O
models	O
resulted	O
in	O
decreased	O
transcriptional	O
activation	O
of	O
IL-2	O
dependent	O
promoters	O
following	O
TCR	other-biologything
stimulation	O
.	O

Among	O
his	O
contributions	O
are	O
the	O
findings	O
that	O
cell	O
surface	O
receptors	O
with	O
tyrosine	other-biologything
kinase	other-biologything
activity	O
signal	O
across	O
membrane	O
by	O
forming	O
dimers	O
when	O
they	O
bind	O
to	O
their	O
growth	O
factor	O
activators	O
.	O

the	O
Arctic	O
cod	O
``	O
Arctogadus	other-biologything
glacialis	other-biologything
``	O
.	O

Protein	other-biologything
Kinase	other-biologything
A	other-biologything
,	O
for	O
example	O
,	O
can	O
phosphorylate	O
tryptophan	other-biologything
hydroxylase	other-biologything
,	O
thus	O
increasing	O
its	O
activity	O
.	O

It	O
was	O
significant	O
in	O
the	O
recognition	O
of	O
aspirin	O
's	O
antithrombotic	O
effect	O
,	O
when	O
general	O
practitioner	O
Lawrence	O
Craven	O
reported	O
in	O
1953	O
that	O
patients	O
who	O
chewed	O
Aspergum	other-biologything
as	O
an	O
analgesic	O
after	O
tonsillectomy	O
tended	O
to	O
bleed	O
more	O
easily	O
.	O

Grb2	O
is	O
composed	O
of	O
an	O
SH2	other-biologything
domain	other-biologything
flanked	O
on	O
each	O
side	O
by	O
an	O
SH3	other-biologything
domain	other-biologything
.	O

Methotrexate	other-biologything
blocks	O
the	O
action	O
of	O
dihydrofolate	other-biologything
reductase	other-biologything
and	O
thereby	O
halts	O
the	O
production	O
of	O
nucleotides	other-biologything
.	O

Thus	O
,	O
TGF-β	other-biologything
blocks	O
advancement	O
through	O
the	O
G1	other-biologything
phase	other-biologything
of	O
the	O
cycle	O
.	O

``	O
TMEM128	other-biologything
``	O
has	O
three	O
variants	O
,	O
varying	O
in	O
5	O
'	O
UTR	O
's	O
and	O
start	O
codon	O
location	O
.	O

In	O
these	O
cases	O
RNase	other-biologything
treatment	O
may	O
be	O
required	O
to	O
reduce	O
background	O
from	O
RNA	other-biologything
in	O
the	O
cells	O
.	O

lysine	other-biologything
acetylation	O
,	O
lysine	other-biologything
and	O
arginine	other-biologything
methylation	O
,	O
serine	other-biologything
and	O
threonine	other-biologything
phosphorylation	O
,	O
and	O
lysine	other-biologything
ubiquitination	O
and	O
sumoylation	O
)	O
play	O
central	O
roles	O
in	O
many	O
types	O
of	O
epigenetic	O
inheritance	O
.	O

Bifidobacterium	other-biologything
have	O
a	O
metabolic	O
pathway	O
for	O
the	O
uptake	O
and	O
digestion	O
of	O
specific	O
human	O
milk	O
oligosaccharides	other-biologything
.	O

A	O
total	O
of	O
1	O
IU/kg	O
of	O
protein	other-biologything
C	other-biologything
concentrate	O
or	O
1	O
mL/kg	O
of	O
fresh	O
frozen	O
plasma	O
will	O
increase	O
the	O
plasma	O
concentration	O
of	O
protein	other-biologything
C	other-biologything
by	O
1	O
IU/dL	O
.	O

When	O
patients	O
are	O
hospitalized	O
and	O
identified	O
as	O
having	O
methicillin-resistant	other-biologything
Staphylococcus	other-biologything
aureus	other-biologything
or	O
infections	O
that	O
can	O
be	O
spread	O
to	O
other	O
patients	O
,	O
best	O
practices	O
isolate	O
these	O
patients	O
in	O
rooms	O
that	O
are	O
subjected	O
to	O
terminal	O
cleaning	O
when	O
the	O
patient	O
is	O
discharged	O
.	O

Phosphorylation	O
of	O
serine	other-biologything
and	O
threonine	other-biologything
residues	O
is	O
known	O
to	O
crosstalk	O
with	O
``	other-biologything
O	other-biologything
''	other-biologything
-GlcNAc	other-biologything
modification	O
of	O
serine	other-biologything
and	O
threonine	other-biologything
residues	O
.	O

OPCs	other-biologything
receive	O
synaptic	O
contacts	O
onto	O
their	O
processes	O
from	O
both	O
glutamatergic	other-biologything
and	O
GABAergic	other-biologything
neurons	O
.	O

For	O
example	O
,	O
some	O
of	O
the	O
natural	O
pigments	O
that	O
produce	O
a	O
rich	O
yolk	O
color	O
are	O
xanthophylls	other-biologything
without	O
much	O
nutritional	O
value	O
,	O
rather	O
than	O
the	O
carotenoids	other-biologything
that	O
act	O
as	O
provitamin	other-biologything
A	other-biologything
in	O
the	O
body	O
.	O

Nutlin-3	O
has	O
been	O
shown	O
to	O
affect	O
the	O
production	O
of	O
p53	other-biologything
within	O
minutes	O
.	O

At	O
least	O
three	O
``	other-biologything
Drosophila	other-biologything
''	other-biologything
hedgehog	other-biologything
homologs	O
have	O
been	O
found	O
in	O
vertebrates	O
:	O
sonic	other-biologything
hedgehog	other-biologything
,	O
desert	other-biologything
hedgehog	other-biologything
,	O
and	O
Indian	other-biologything
hedgehog	other-biologything
.	O

At	O
low	O
nM	other-biologything
concentrations	O
,	O
leptomycin	O
B	O
blocks	O
the	O
nuclear	O
export	O
of	O
many	O
proteins	O
including	O
HIV-1	other-biologything
Rev	other-biologything
,	O
MAPK/ERK	other-biologything
,	O
and	O
NF-κB/IκB	other-biologything
,	O
and	O
it	O
inhibits	O
the	O
inactivation	O
of	O
p53	other-biologything
.	O

FK1012	other-biologything
is	O
a	O
dimer	O
of	O
tacrolimus	other-biologything
;	O
the	O
two	O
tacrolimus	other-biologything
units	O
are	O
linked	O
at	O
their	O
vinyl	other-biologything
groups	other-biologything
.	O

Thrombin	other-biologything
is	O
an	O
enzyme	O
that	O
splits	O
fibrinogen	other-biologything
into	O
fibrin	other-biologything
monomers	other-biologything
in	O
10	O
to	O
60	O
seconds	O
,	O
which	O
aggregate	O
to	O
form	O
a	O
three-dimensional	O
gel-like	O
structure	O
.	O

In	O
one	O
example	O
,	O
filopodia-like	O
protrusions	O
,	O
or	O
tunneling	O
nanotubes	O
directed	O
toward	O
neighboring	O
cells	O
in	O
a	O
culture	O
of	O
rat	O
PC12	other-biologything
cells	O
have	O
been	O
shown	O
to	O
facilitate	O
transport	O
of	O
organelles	O
through	O
transient	O
membrane	O
fusion	O
.	O

In	O
the	O
early	O
1960s	O
,	O
Porton	O
Down	O
was	O
asked	O
to	O
expand	O
the	O
scope	O
of	O
their	O
tests	O
to	O
determine	O
if	O
using	O
a	O
live	O
bacteria	O
instead	O
of	O
ZnCds	other-biologything
would	O
significantly	O
alter	O
the	O
results	O
.	O

There	O
are	O
multiple	O
disorders	O
associated	O
with	O
improper	O
GFAP	other-biologything
regulation	O
,	O
and	O
injury	O
can	O
cause	O
glial	other-biologything
cells	other-biologything
to	O
react	O
in	O
detrimental	O
ways	O
.	O

The	O
biological	O
effects	O
of	O
IFNs	other-biologything
are	O
mediated	O
through	O
the	O
Janus	other-biologything
kinase	other-biologything
/signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(	O
JAK	other-biologything
/	O
STAT	other-biologything
)	O
pathway	O
.	O

ATP	other-biologything
is	O
synthesized	O
by	O
way	O
of	O
a	O
cytochrome	O
c	O
oxidase	O
catalyzed	O
termination	O
.	O

SR	other-biologything
protein	other-biologything
SC35	other-biologything
has	O
the	O
ability	O
to	O
bind	O
to	O
the	O
largest	O
subunit	O
of	O
RNA	other-biologything
polymerase	O
II	O
at	O
the	O
phosphorylated	O
C-terminal	O
domain	O
.	O

Tryptone	other-biologything
is	O
the	O
assortment	O
of	O
peptides	other-biologything
formed	O
by	O
the	O
digestion	O
of	O
casein	other-biologything
by	O
the	O
protease	O
trypsin	O
.	O

However	O
,	O
participants	O
who	O
completed	O
the	O
two	O
values	O
essays	O
did	O
not	O
show	O
an	O
increase	O
in	O
catecholamine	other-biologything
levels	O
from	O
baseline	O
to	O
their	O
midterm	O
.	O

Recent	O
DNA	other-biologything
profiling	O
conducted	O
at	O
the	O
research	O
facility	O
in	O
San	O
Michele	O
all'Adige	O
revealed	O
Marzemino	O
to	O
have	O
a	O
parent-offspring	O
relationship	O
with	O
the	O
grapes	O
Marzemina	O
bianca	O
in	O
the	O
Veneto	O
,	O
Refosco	O
dal	O
Peduncolo	O
Rosso	O
and	O
Teroldego	O
,	O
from	O
Friuli-Venezia	O
Giulia	O
and	O
Trentino	O
respectively	O
,	O
which	O
gives	O
further	O
evidence	O
to	O
its	O
likely	O
origins	O
in	O
this	O
region	O
.	O

Eventually	O
,	O
changes	O
in	O
the	O
echotexture	O
of	O
the	O
corpora	other-biologything
cavernosa	other-biologything
can	O
be	O
observed	O
due	O
to	O
the	O
fibrotic	O
transformation	O
generated	O
by	O
tissue	O
anoxia	O
.	O

The	O
positive	O
B	O
cell	O
signaling	O
is	O
initiated	O
by	O
binding	O
of	O
foreign	other-biologything
antigen	other-biologything
to	O
surface	other-biologything
immunoglobulin	other-biologything
.	O

The	O
significance	O
of	O
TGF-β	other-biologything
is	O
apparent	O
with	O
the	O
human	O
diseases	O
that	O
occur	O
when	O
TGF-β	other-biologything
processes	O
are	O
disrupted	O
,	O
such	O
as	O
cancer	O
,	O
and	O
skeletal	O
,	O
intestinal	O
and	O
cardiovascular	O
diseases	O
.	O

The	O
cheese	O
may	O
contain	O
beneficial	O
probiotics	other-biologything
.	O

Mutation	O
results	O
from	O
damage	O
when	O
mistakes	O
in	O
the	O
mechanism	O
of	O
DNA	other-biologything
repair	O
causes	O
a	O
change	O
in	O
nucleotide	other-biologything
sequence	O
,	O
or	O
if	O
replication	O
occurs	O
before	O
repair	O
is	O
complete	O
.	O

However	O
,	O
this	O
region	O
contains	O
another	O
gene	O
TPPP	other-biologything
which	O
may	O
be	O
the	O
causative	O
gene	O
.	O

Lectin	other-biologything
affinity	O
chromatography	O
is	O
a	O
form	O
of	O
affinity	O
chromatography	O
where	O
lectins	O
are	O
used	O
to	O
separate	O
components	O
within	O
the	O
sample	O
.	O

Results	O
show	O
that	O
fibrin	other-biologything
glue	other-biologything
fixation	O
is	O
easy	O
,	O
reliable	O
and	O
efficient	O
with	O
the	O
corneal	O
surface	O
.	O

Transcription	O
of	O
the	O
c-Fos	other-biologything
gene	other-biologything
in	O
response	O
to	O
serum	O
stimulation	O
can	O
,	O
for	O
the	O
most	O
part	O
,	O
be	O
summarised	O
by	O
two	O
states	O
,	O
although	O
at	O
certain	O
times	O
after	O
stimulation	O
,	O
a	O
third	O
state	O
better	O
explains	O
the	O
variance	O
in	O
the	O
data	O
.	O

It	O
is	O
in	O
the	O
same	O
family	O
as	O
the	O
SnoN	other-biologything
protein	other-biologything
.	O

RNA	other-biologything
polymerase	other-biologything
II	other-biologything
holoenzyme	O
stability	O
determines	O
the	O
number	O
of	O
base	O
pairs	O
that	O
can	O
be	O
transcribed	O
before	O
the	O
holoenzyme	O
loses	O
its	O
ability	O
to	O
transcribe	O
.	O

N-alpha	other-biologything
methyltransferases	other-biologything
transfer	O
a	O
methyl	O
group	O
from	O
SAM	other-biologything
to	O
the	O
N-terminal	other-biologything
nitrogen	other-biologything
on	O
protein	O
targets	O
.	O

This	O
relationship	O
is	O
further	O
supported	O
by	O
the	O
fact	O
that	O
mice	O
lacking	O
NMNAT2	other-biologything
,	O
which	O
are	O
normally	O
not	O
viable	O
,	O
are	O
completely	O
rescued	O
by	O
SARM1	other-biologything
deletion	O
,	O
placing	O
NMNAT2	other-biologything
activity	O
upstream	O
of	O
SARM1	other-biologything
.	O

Humans	O
with	O
MC1R	other-biologything
mutations	O
have	O
been	O
reported	O
to	O
need	O
approximately	O
20	O
%	O
more	O
Inhalational	O
anaesthetic	O
than	O
controls	O
.	O

Norepinephrine	other-biologything
is	O
a	O
neurotransmitter	O
that	O
is	O
involved	O
with	O
learning	O
,	O
memory	O
,	O
and	O
physical	O
arousal	O
.	O

Their	O
activity	O
primarily	O
involves	O
the	O
binding	O
and	O
inhibition	O
of	O
G1/S-	other-biologything
and	O
S-Cdks	other-biologything
;	O
however	O
,	O
they	O
have	O
also	O
been	O
shown	O
to	O
play	O
an	O
important	O
role	O
in	O
activating	O
the	O
G1-CDKs	other-biologything
CDK4	other-biologything
and	O
CDK6	other-biologything
.	O

Small	other-biologything
RNAs	other-biologything
mainly	O
include	O
5.8S	other-biologything
ribosomal	other-biologything
RNA	other-biologything
(	O
rRNA	other-biologything
)	O
,	O
5S	other-biologything
rRNA	other-biologything
,	O
transfer	other-biologything
RNA	other-biologything
(	O
tRNA	other-biologything
)	O
,	O
microRNA	other-biologything
(	O
miRNA	other-biologything
)	O
,	O
small	other-biologything
interfering	other-biologything
RNA	other-biologything
(	O
siRNA	other-biologything
)	O
,	O
small	other-biologything
nucleolar	other-biologything
RNA	other-biologything
(	O
snoRNAs	other-biologything
)	O
,	O
Piwi-interacting	other-biologything
RNA	other-biologything
(	O
piRNA	other-biologything
)	O
,	O
tRNA-derived	other-biologything
small	other-biologything
RNA	other-biologything
(	O
tsRNA	other-biologything
)	O
and	O
small	other-biologything
rDNA-derived	other-biologything
RNA	other-biologything
(	O
srRNA	other-biologything
)	O
.	O

Monascus	other-biologything
pallens	O
is	O
a	O
fungal	O
species	O
in	O
the	O
Monascaceae	other-biologything
family	O
.	O

This	O
allows	O
the	O
adaptor	O
molecule	O
FADD	other-biologything
to	O
bind	O
the	O
death	other-biologything
domain	other-biologything
of	O
Fas	other-biologything
through	O
its	O
own	O
death	other-biologything
domain	other-biologything
.	O

Enzymatic	other-biologything
proteolysis	other-biologything
at	O
this	O
site	O
is	O
carried	O
out	O
by	O
a	O
A	other-biologything
Disintegrin	other-biologything
and	other-biologything
Metalloprotease	other-biologything
domain	O
(	O
ADAM	other-biologything
)	O
family	O
protease	O
.	O

The	O
acetylation	O
of	O
p53	other-biologything
is	O
indispensable	O
for	O
its	O
activation	O
.	O

For	O
example	O
,	O
acetate-forming	other-biologything
bacteria	other-biologything
use	O
acetyl-CoA	other-biologything
for	O
their	O
autotrophic	O
growth	O
processes	O
,	O
and	O
methanogenic	O
archae	O
such	O
as	O
``	O
Methanocarcina	other-biologything
barkeri	other-biologything
``	O
convert	O
the	O
acetyl-CoA	other-biologything
into	O
acetate	other-biologything
and	O
use	O
it	O
as	O
an	O
alternative	O
source	O
of	O
carbon	O
instead	O
of	O
CO	O
.	O

When	O
more	O
R5P	other-biologything
is	O
needed	O
than	O
NADPH	other-biologything
,	O
R5P	other-biologything
can	O
be	O
formed	O
through	O
glycolytic	O
intermediates	O
.	O

Because	O
of	O
that	O
,	O
the	O
equilibrium	O
between	O
the	O
lactone	other-biologything
ring	other-biologything
and	O
the	O
carboxylate	other-biologything
form	O
is	O
driven	O
toward	O
the	O
carboxylate	other-biologything
.	O

Activated	O
protein	other-biologything
C	other-biologything
is	O
a	O
natural	O
anticoagulant	O
that	O
acts	O
to	O
limit	O
the	O
extent	O
of	O
clotting	O
by	O
cleaving	O
and	O
degrading	O
factor	other-biologything
V	other-biologything
.	O

Further	O
investigation	O
revealed	O
that	O
mutant	O
EGFR	other-biologything
could	O
activate	O
the	O
oncogenic	O
STAT3	other-biologything
pathway	O
via	O
upregulated	O
IL-6	other-biologything
autocrine	O
signaling	O
.	O

Each	O
reported	O
mutation	O
was	O
truncating	O
(	O
nonsense	O
or	O
frameshift	O
)	O
and	O
occurred	O
between	O
codons	O
2,407	O
and	O
2,517	O
in	O
exon	other-biologything
34	other-biologything
,	O
resulting	O
in	O
the	O
loss	O
of	O
three	O
C-terminal	other-biologything
AT-hook	other-biologything
motifs	other-biologything
.	O

Certain	O
paramyxoviruses	O
avoid	O
the	O
interferon	O
response	O
in	O
cells	O
by	O
targeting	O
STAT1	other-biologything
and	O
disrupting	O
signaling	O
.	O

Estrogens	other-biologything
can	O
be	O
used	O
to	O
suppress	O
and	O
cease	O
lactation	O
and	O
breast	O
engorgement	O
in	O
postpartum	O
women	O
who	O
do	O
not	O
wish	O
to	O
breastfeed	O
.	O

Until	O
2015	O
all	O
known	O
mammalian	O
prion	other-biologything
diseases	O
were	O
considered	O
to	O
be	O
caused	O
by	O
the	O
prion	other-biologything
protein	other-biologything
,	O
PrP	other-biologything
;	O
in	O
2015	O
multiple	O
system	O
atrophy	O
was	O
found	O
to	O
be	O
transmissible	O
and	O
was	O
hypothesized	O
to	O
be	O
caused	O
by	O
a	O
new	O
prion	other-biologything
,	O
the	O
misfolded	O
form	O
of	O
a	O
protein	other-biologything
called	O
alpha-synuclein	other-biologything
.	O

Norepinephrine	other-biologything
(	O
NE	other-biologything
)	O
is	O
released	O
by	O
the	O
Locus	other-biologything
coeruleus	other-biologything
,	O
it	O
is	O
then	O
transferred	O
to	O
the	O
limbic	O
system	O
where	O
much	O
of	O
the	O
memory	O
consolidation	O
and	O
fight	O
or	O
flight	O
responses	O
are	O
facilitated	O
.	O

Cdc6	O
and	O
Cdt1	O
assemble	O
on	O
the	O
ORC	O
and	O
recruit	O
the	O
Mcm	other-biologything
proteins	other-biologything
.	O

Found	O
in	O
all	O
living	O
cells	O
,	O
NAD	other-biologything
is	O
called	O
a	O
dinucleotide	other-biologything
because	O
it	O
consists	O
of	O
two	O
nucleotides	other-biologything
joined	O
through	O
their	O
phosphate	other-biologything
groups	other-biologything
.	O

Additionally	O
,	O
p53	other-biologything
bound	O
to	O
E1B-55k	other-biologything
has	O
an	O
affinity	O
for	O
its	O
binding	O
site	O
that	O
is	O
ten	O
times	O
higher	O
than	O
free	O
p53	other-biologything
.	O

Aspartokinases	other-biologything
are	O
present	O
only	O
in	O
microorganisms	O
and	O
plants	O
,	O
but	O
not	O
in	O
animals	O
,	O
which	O
must	O
obtain	O
aspartate-family	O
amino	O
acids	O
from	O
their	O
diet	O
.	O

The	O
induction	O
of	O
the	O
p14arf	other-biologything
protein	O
,	O
the	O
alternate	O
reading	O
frame	O
product	O
of	O
the	O
p16INK4a	other-biologything
locus	O
,	O
is	O
also	O
a	O
mechanism	O
of	O
negatively	O
regulating	O
the	O
p53-Mdm2	other-biologything
interaction	O
.	O

showed	O
that	O
this	O
riboswitch	O
senses	O
and	O
responds	O
to	O
guanidine	O
and	O
it	O
was	O
renamed	O
Guanidine-I	other-biologything
riboswitch	O
.	O

In	O
addition	O
,	O
canonical	O
type	other-biologything
I	other-biologything
IFN	other-biologything
signalling	O
may	O
activate	O
STAT1	other-biologything
homodimers	O
that	O
bind	O
to	O
interferon-gamma-activating	O
factor	O
(	O
GAF	other-biologything
)	O
,	O
which	O
also	O
translocates	O
to	O
the	O
nucleus	O
and	O
activates	O
transcription	O
of	O
IFN	other-biologything
-stimulated	O
genes	O
.	O

Also	O
,	O
it	O
is	O
known	O
that	O
PIAS1	other-biologything
can	O
inhibit	O
NF-κB	other-biologything
activity	O
upon	O
stimulation	O
by	O
the	O
cytokine	other-biologything
TNF	other-biologything
and	O
the	O
LPS	other-biologything
endotoxin	other-biologything
.	O

TGF-β	other-biologything
is	O
a	O
multifunctional	O
set	O
of	O
peptides	O
that	O
controls	O
proliferation	O
,	O
differentiation	O
,	O
and	O
other	O
functions	O
in	O
many	O
cell	O
types	O
.	O

It	O
has	O
been	O
shown	O
that	O
tryptophan	other-biologything
2	other-biologything
,	O
3-dioxygenase	other-biologything
is	O
expressed	O
in	O
a	O
significant	O
proportion	O
of	O
human	O
tumors	O
.	O

Also	O
promoting	O
cell	O
survival	O
,	O
cAMP	other-biologything
response	O
element	O
binding	O
protein	O
(	O
CREB	other-biologything
)	O
is	O
phosphorylated	O
by	O
Akt	other-biologything
at	O
Ser133	other-biologything
,	O
stimulating	O
recruitment	O
of	O
CREB	other-biologything
-binding	O
protein	O
(	O
CBP	other-biologything
)	O
to	O
the	O
promoter	O
of	O
target	O
genes	O
,	O
such	O
as	O
Bcl-2	other-biologything
.	O

A	O
link	O
between	O
laughter	O
and	O
healthy	O
function	O
of	O
blood	O
vessels	O
was	O
first	O
reported	O
in	O
2005	O
by	O
researchers	O
at	O
the	O
University	O
of	O
Maryland	O
Medical	O
Center	O
with	O
the	O
fact	O
that	O
laughter	O
causes	O
the	O
dilatation	O
of	O
the	O
inner	O
lining	O
of	O
blood	O
vessels	O
,	O
the	other-biologything
endothelium	other-biologything
,	O
and	O
increases	O
blood	O
flow	O
.	O

Mutant	other-biologything
p53	other-biologything
proteins	O
often	O
fail	O
to	O
induce	O
MDM2	other-biologything
,	O
causing	O
p53	other-biologything
to	O
accumulate	O
at	O
very	O
high	O
levels	O
.	O

Three	O
of	O
these	O
are	O
present	O
in	O
the	other-biologything
ATP	other-biologything
synthase	other-biologything
molecule	other-biologything
,	other-biologything
and	O
is	O
therefore	O
designated	O
α3	other-biologything
.	O

The	O
pathogens	O
are	O
usually	O
``	O
Candida	other-biologything
albicans	other-biologything
``	O
and	O
``	O
Candida	other-biologything
parapsilosis	other-biologything
``	O
.	O

Hemoglobin	other-biologything
A	other-biologything
is	O
eluted	O
regardless	O
of	O
whether	O
it	O
is	O
oxyhemoglobin	other-biologything
,	O
methemoglobin	other-biologything
,	O
cyanmethemoglobin	other-biologything
,	O
reduced	other-biologything
hemoglobin	other-biologything
,	O
or	O
carboxyhemoglobin	other-biologything
.	O

This	O
continued	O
inward	O
current	O
prolongs	O
the	O
action	O
potential	O
and	O
thereby	O
the	O
QT	other-biologything
interval	other-biologything
.	O

Glutamine	other-biologything
is	O
the	O
NH3	other-biologything
donor	O
and	O
the	O
reaction	O
is	O
fueled	O
by	O
ATP	other-biologything
hydrolysis	O
,	O
too	O
:	O

The	O
dolichol	other-biologything
phosphate	other-biologything
cycle	O
plays	O
a	O
major	O
role	O
in	O
the	O
synthesis	O
of	O
glycoproteins	other-biologything
.	O

Insulin	O
therapy	O
is	O
not	O
the	O
same	O
as	O
IPT	other-biologything
low-dose	O
chemotherapy	O
.	O

Osteopontin	other-biologything
(	O
OPN	other-biologything
)	O
,	O
also	O
known	O
as	O
bone	other-biologything
sialoprotein	other-biologything
I	other-biologything
(	O
BSP-1	other-biologything
or	O
BNSP	other-biologything
)	O
,	O
early	O
T-lymphocyte	other-biologything
activation	O
(	O
ETA-1	other-biologything
)	O
,	O
secreted	other-biologything
phosphoprotein	other-biologything
1	other-biologything
(	O
SPP1	other-biologything
)	O
,	O
2ar	other-biologything
and	O
Rickettsia	other-biologything
resistance	other-biologything
(	O
Ric	other-biologything
)	O
,	O
is	O
a	O
protein	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
SPP1	other-biologything
``	O
gene	O
(	O
secreted	other-biologything
phosphoprotein	other-biologything
1	other-biologything
)	O
.	O

The	O
binding	O
site	O
of	O
heparin	other-biologything
is	O
different	O
for	O
protein	other-biologything
C	other-biologything
inhibitor	other-biologything
and	O
other	O
proteases	other-biologything
Heparin	other-biologything
regulates	O
the	O
protein	other-biologything
C	other-biologything
inhibitor	other-biologything
(	O
PCI	other-biologything
)	O
activity	O
and	O
furthermore	O
its	O
specificity	O
in	O
those	O
system	O
where	O
there	O
is	O
presence	O
of	O
two	O
or	O
more	O
target	O
proteases	other-biologything
.	O

The	O
activity	O
of	O
tryptophan	other-biologything
hydroxylase	other-biologything
(	O
i.e	O
.	O

[	O
8	O
]	O
This	O
channel	O
provides	O
the	O
pathway	O
through	O
which	O
K+	other-biologything
is	O
secreted	O
into	O
the	O
endolymph	O
.	O

In	O
this	O
sample	O
,	O
they	O
discovered	O
the	O
presence	O
of	O
H.	other-biologything
pylori	other-biologything
.	O

The	O
two	O
major	O
types	O
of	O
clathrin	other-biologything
adaptor	other-biologything
complexes	other-biologything
are	O
the	O
heterotetrameric	other-biologything
adaptor	other-biologything
protein	other-biologything
(	other-biologything
AP	other-biologything
)	other-biologything
complexes	other-biologything
,	O
and	O
the	O
monomeric	other-biologything
GGA	other-biologything
(	O
Golgi-localising	other-biologything
,	O
Gamma-adaptin	other-biologything
ear	other-biologything
domain	other-biologything
homology	other-biologything
,	O
ARF-binding	other-biologything
proteins	other-biologything
)	O
adaptors	O
.	O

Acyl-CoA	other-biologything
Synthetase	other-biologything
,	other-biologything
Bubblegum	other-biologything
Family	other-biologything
,	other-biologything
member	other-biologything
1	other-biologything
(	O
ACSBG1	other-biologything
)	O
is	O
an	O
enzyme	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
ACSBG1	other-biologything
``	O
gene	O
.	O

DNAJC5	other-biologything
appears	O
to	O
have	O
a	O
role	O
in	O
stimulated	O
exocytosis	O
.	O

The	O
Arp5	other-biologything
subunit	O
is	O
required	O
for	O
ATPase	other-biologything
function	O
,	O
binding	O
to	O
the	O
DNA	other-biologything
,	O
and	O
relocation	O
of	O
nucleosomes	O
.	O

The	O
alpha-gal	O
allergy	O
is	O
believed	O
to	O
result	O
from	O
tick	other-biologything
bites	O
.	O

Thayer-Martin	other-biologything
agar	O
is	O
a	O
chocolate	other-biologything
agar	other-biologything
plate	other-biologything
(	O
heated	other-biologything
blood	other-biologything
agar	other-biologything
)	O
containing	O
nutrients	O
and	O
antimicrobials	other-biologything
(	O
vancomycin	other-biologything
,	O
colistin	other-biologything
,	O
nystatin	other-biologything
,	O
and	O
trimethoprim	other-biologything
)	O
.	O

CPA3	other-biologything
is	O
one	O
of	O
8-9	O
members	O
of	O
the	O
A/B	O
subfamily	O
that	O
includes	O
the	O
well-studied	O
pancreatic	O
enzymes	O
carboxypeptidase	other-biologything
A1	other-biologything
(	O
CPA1	other-biologything
)	O
,	O
carboxypeptidase	other-biologything
A2	other-biologything
(	O
CPA2	other-biologything
)	O
,	O
and	O
carboxypeptidase	other-biologything
B	other-biologything
.	O

Isoniazid	other-biologything
is	O
associated	O
with	O
pyridoxine	other-biologything
(	O
vitamin	other-biologything
B6	other-biologything
)	O
deficiency	O
because	O
of	O
its	O
similar	O
structure	O
.	O

Fibronectin	other-biologything
leucine	other-biologything
rich	other-biologything
transmembrane	other-biologything
protein	other-biologything
1	other-biologything
is	O
a	O
protein	other-biologything
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
FLRT1	other-biologything
gene	O
.	O

Keller	O
chose	O
restaurant/hotel	O
designer	O
Adam	O
Tihany	O
to	O
draw	O
together	O
subtle	O
references	O
to	O
The	O
French	O
Laundry	O
and	O
elements	other-biologything
from	O
both	O
his	O
and	O
Keller	O
's	O
pasts	O
;	O
for	O
example	O
,	O
the	O
decorative	O
blue	O
door	O
at	O
the	O
main	O
entrance	O
is	O
modeled	O
after	O
the	O
blue	O
door	O
at	O
The	O
French	O
Laundry	O
.	O

This	O
leads	O
to	O
a	O
missense	O
mutation	O
from	O
Arginine	other-biologything
to	O
Tryptophan	other-biologything
at	O
the	O
234	O
position	O
of	O
the	O
RLBP1	other-biologything
.	O

One	O
study	O
done	O
in	O
2011	O
achieves	O
successful	O
CD4+	other-biologything
T-cell	other-biologything
reconstitution	O
as	O
a	O
result	O
of	O
CCR5Δ32/Δ32	other-biologything
stem	O
cell	O
transplantation	O
at	O
the	O
systemic	O
level	O
and	O
in	O
the	O
gut	O
mucosal	O
immune	O
system	O
in	O
a	O
patient	O
with	O
HIV	other-biologything
.	O

Disulfide	O
linkages	O
between	O
4	O
of	O
the	O
6	other-biologything
cysteine	other-biologything
residues	O
in	O
the	O
extracellular	O
loop	O
are	O
required	O
for	O
efficient	O
intracellular	O
processing	O
and	O
transport	O
of	O
CD36	other-biologything
to	O
the	O
plasma	O
membrane	O
.	O

Monocytes	O
derived	O
from	O
``	O
Cnn2	other-biologything
``	O
gene	O
knockout	O
mice	O
proliferated	O
faster	O
than	O
wild	O
type	O
control	O
cells	O
.	O

Many	O
studies	O
have	O
provided	O
insight	O
into	O
the	O
normal	O
function	O
of	O
the	O
DISC1	other-biologything
protein	O
,	O
though	O
much	O
remains	O
to	O
be	O
clearly	O
defined	O
.	O

The	O
structural	O
organisation	O
of	O
domain	O
I	O
is	O
closely	O
related	O
to	O
FAD	other-biologything
-containing	O
monooxygenases	other-biologything
and	O
oxidases	other-biologything
.	O

Amantadine	other-biologything
’	O
s	O
effectiveness	O
stems	O
from	O
the	O
IRES	other-biologything
location	O
on	O
the	O
5	other-biologything
’	other-biologything
NTR	other-biologything
region	O
which	O
has	O
a	O
high	O
affinity	O
for	O
antivirals	O
making	O
it	O
an	O
effective	O
target	O
.	O

Experimental	O
evidence	O
also	O
supports	O
that	O
mPRs	other-biologything
are	O
intermediaries	O
in	O
progestin-induced	other-biologything
cell	other-biologything
survival	O
.	O

The	O
two	O
most	O
conserved	O
regions	O
form	O
a	O
compact	O
structure	O
at	O
the	O
apex	O
of	O
the	O
molecule	O
;	O
site-directed	O
mutagenesis	O
has	O
shown	O
these	O
regions	O
to	O
play	O
a	O
critical	O
role	O
in	O
the	O
binding	O
of	O
Rab	other-biologything
proteins	other-biologything
.	O

One	O
of	O
these	O
mechanisms	O
is	O
phosphorylation	O
of	O
the	O
Mdm2	other-biologything
protein	other-biologything
.	O

Along	O
with	O
his	O
research	O
team	O
,	O
Hayden	O
has	O
identified	O
10	O
disease-causing	O
genes	O
,	O
which	O
includes	O
the	O
identification	O
of	O
the	O
major	O
gene	O
underlying	O
high-density	other-biologything
lipoprotein	other-biologything
(	O
HDL	other-biologything
)	O
in	O
humans	O
.	O

Suuwassea	other-biologything
(	O
meaning	O
``	O
ancient	O
thunder	O
''	O
)	O
is	O
a	O
genus	O
of	O
dicraeosaurid	O
sauropod	O
dinosaur	other-biologything
found	O
in	O
the	O
Upper	O
Jurassic	O
strata	O
of	O
the	O
Morrison	O
Formation	O
,	O
located	O
in	O
southern	O
Carbon	O
County	O
,	O
Montana	O
,	O
United	O
States	O
.	O

The	O
sperm	O
must	O
provide	O
the	O
zygote	other-biologything
with	O
DNA	other-biologything
,	O
centrioles	other-biologything
,	O
and	O
activation	O
factor	O
for	O
the	O
embryo	O
to	O
develop	O
.	O

In	O
human	O
antithrombin	other-biologything
this	O
bond	O
is	O
between	O
arginine	other-biologything
(	other-biologything
arg	other-biologything
)	other-biologything
393	other-biologything
and	O
serine	other-biologything
(	other-biologything
ser	other-biologything
)	other-biologything
394	other-biologything
(	O
see	O
Figure	O
2	O
and	O
Figure	O
3	O
)	O
.	O

The	O
absence	O
of	O
p21	other-biologything
or	O
14-3-3	other-biologything
can	O
not	O
sufficiently	O
inhibit	O
the	O
CyclinB-Cdc2	other-biologything
complex	other-biologything
,	O
thus	O
exhibiting	O
the	O
regulatory	O
control	O
of	O
p53	other-biologything
and	O
p21	other-biologything
in	O
the	O
G2	other-biologything
checkpoint	O
in	O
response	O
to	O
DNA	other-biologything
damage	O
.	O

CRL4Cdt2	other-biologything
also	O
degrades	O
PCNA-bound	other-biologything
PR-Set7/SET8	other-biologything
,	O
which	O
is	O
a	O
histone	other-biologything
4	other-biologything
methyltransferase	other-biologything
,	O
and	O
the	O
p12	other-biologything
subunit	O
of	O
DNA	other-biologything
polymerase	O
δ	other-biologything
,	other-biologything
which	O
is	O
crucial	O
for	O
DNA	other-biologything
replication	O
.	O

Long	other-biologything
RNAs	other-biologything
,	O
also	O
called	O
large	other-biologything
RNAs	other-biologything
,	O
mainly	O
include	O
long	other-biologything
non-coding	other-biologything
RNA	other-biologything
(	O
lncRNA	other-biologything
)	O
and	O
mRNA	other-biologything
.	O

During	O
inspiration	O
,	O
right	O
ventricle	other-biologything
filling	O
in	O
increased	O
,	O
which	O
causes	O
the	O
Interventricular	other-biologything
septum	other-biologything
to	O
bulge	O
into	O
the	O
left	O
ventricle	other-biologything
,	O
hence	O
leading	O
to	O
reduced	O
left	O
ventricular	O
filling	O
and	O
consequently	O
reduced	O
stroke	O
volume	O
and	O
low	O
systolic	O
blood	O
pressure	O
.	O

Hyphae	other-biologything
are	O
sparse	O
,	O
and	O
inflammatory	other-biologything
cell	other-biologything
infiltration	O
of	O
the	O
epithelium	O
and	O
the	O
lamina	O
propria	O
.	O

Although	O
inhibition	O
of	O
geminin	O
by	O
RNAi	other-biologything
leads	O
to	O
impairment	O
of	O
DNA	other-biologything
replication	O
during	O
the	O
following	O
cell	O
cycle	O
in	O
many	O
cancer	O
cell	O
lines	O
,	O
no	O
such	O
cell	O
cycle	O
defect	O
is	O
seen	O
in	O
primary	O
and	O
immortalized	other-biologything
cell	other-biologything
lines	other-biologything
(	O
although	O
Cdt1	other-biologything
levels	O
are	O
still	O
reduced	O
in	O
these	O
cells	O
)	O
.	O

It	O
is	O
the	O
common	O
pathway	O
for	O
enhancing	O
expression	O
of	O
a	O
variety	O
of	O
IFNγ	other-biologything
-inducible	O
genes	O
,	O
accounting	O
for	O
the	O
confinement	O
and	O
killing	O
of	O
intracellular	O
pathogens	O
.	O

Parnara	O
ogasawarensis	O
is	O
a	O
butterfly	O
in	O
the	O
family	O
Hesperiidae	other-biologything
(	O
Hesperiinae	other-biologything
)	O
.	O

The	O
image	O
to	O
the	O
right	O
shows	O
the	O
particular	O
horseshoe-like	O
structure	O
of	O
a	O
protein	O
with	O
many	O
leucine	other-biologything
rich	O
repeats	O
.	O

This	O
gene	O
encodes	O
a	O
member	O
of	O
the	O
ganglioside-induced	other-biologything
differentiation-associated	O
protein	O
family	O
,	O
which	O
may	O
play	O
a	O
role	O
in	O
a	O
signal	O
transduction	O
pathway	O
during	O
neuronal	O
development	O
.	O

This	O
is	O
accomplished	O
through	O
specific	O
transporter	other-biologything
proteins	other-biologything
and	O
glycosidases	other-biologything
to	O
cleave	O
chemical	O
bonds	O
found	O
in	O
lacto-N-tetraose	other-biologything
,	O
lacto-N-neotetraose	other-biologything
,	O
and	O
other	O
human	O
milk	O
oligosaccharides	O
.	O

The	O
most	O
common	O
mode	O
of	O
inheritance	O
is	O
autosomal	other-biologything
dominant	other-biologything
with	other-biologything
reduced	other-biologything
penetrance	other-biologything
,	O
while	O
autosomal	other-biologything
recessive	other-biologything
and	O
X-linked	other-biologything
forms	other-biologything
occur	O
more	O
rarely	O
.	O

Overexpression	O
of	O
c-jun	other-biologything
in	O
cells	O
results	O
in	O
decreased	O
level	O
of	O
p53	other-biologything
and	O
p21	other-biologything
,	O
and	O
exhibits	O
accelerated	O
cell	O
proliferation	O
.	O

When	O
the	O
genus	O
``	O
Metasequoia	other-biologything
``	O
was	O
first	O
described	O
in	O
1941	O
,	O
it	O
was	O
from	O
Mesozoic	O
Era	O
fossils	O
,	O
none	O
of	O
which	O
were	O
less	O
than	O
150	O
million	O
years	O
old	O
.	O

Initially	O
,	O
the	O
activation	O
of	O
Wnt	other-biologything
/	O
beta-catenin	other-biologything
is	O
essential	O
for	O
committing	O
mesenchymal	other-biologything
cells	other-biologything
to	O
a	O
cardiac	O
lineage	O
;	O
however	O
,	O
in	O
later	O
stages	O
of	O
development	O
,	O
the	O
downregulation	O
of	O
beta-catenin	other-biologything
is	O
required	O
.	O

Subsequent	O
functional	O
analysis	O
of	O
a	O
group	O
of	O
1b	O
cases	O
found	O
them	O
not	O
only	O
to	O
have	O
reduced	O
heparin	other-biologything
affinity	O
but	O
multiple	O
or	O
'pleiotrophic	O
'	O
abnormalities	other-biologything
affecting	O
the	O
reactive	O
site	O
,	O
the	O
heparin	other-biologything
binding	O
site	O
and	O
antithrombin	other-biologything
blood	O
concentration	O
.	O

Importantly	O
though	O
,	O
the	O
human	O
gastruloid	other-biologything
model	other-biologything
is	O
not	O
able	O
to	O
form	O
a	O
human	O
embryo	other-biologything
,	O
meaning	O
that	O
is	O
a	O
non-intact	O
,	O
non-viable	O
and	O
non-equivalent	O
to	O
``	O
in	O
vivo	O
''	O
human	O
embryos	other-biologything
.	O

When	O
7q	other-biologything
is	O
altered	O
by	O
a	O
deletion	O
or	O
a	O
translocation	O
ectrodactyly	O
can	O
sometimes	O
be	O
associated	O
with	O
hearing	O
loss	O
.	O

CDC25A	other-biologything
is	O
required	O
for	O
progression	O
from	O
G1	O
to	O
the	O
S	O
phase	O
of	O
the	O
cell	O
cycle	O
,	O
but	O
also	O
plays	O
roles	O
in	O
later	O
cell	O
cycle	O
events	O
.	O

MEK	other-biologything
activates	O
MAPK	other-biologything
(	O
also	O
known	O
as	O
ERK	other-biologything
)	O
,	O
which	O
can	O
go	O
on	O
to	O
regulate	O
transcription	O
and	O
translation	O
.	O

Hayden	O
also	O
identified	O
the	O
first	O
mutations	O
underlying	O
Lipoprotein	other-biologything
lipase	other-biologything
deficiency	O
(	O
LPL	other-biologything
)	O
and	O
developed	O
gene	O
therapy	O
approaches	O
to	O
treat	O
this	O
condition	O
,	O
the	O
first	O
approved	O
gene	O
therapy	O
in	O
the	O
western	O
world	O
.	O

In	O
2012	O
,	O
the	O
P53	other-biologything
gene	O
mutation	O
was	O
shown	O
to	O
increase	O
hPG80	other-biologything
-dependent	O
colon	O
cells	O
proliferation	O
and	O
colon	O
cancer	O
formation	O
in	O
mice	O
.	O

PC12	other-biologything
cells	other-biologything
showed	O
decreased	O
cell	O
replication	O
and	O
growth	O
,	O
increased	O
oxidative	O
stress	O
,	O
and	O
altered	O
cellular	O
differentiation	O
.	O

HDA	other-biologything
was	O
developed	O
from	O
this	O
concept	O
,	O
using	O
a	O
helicase	other-biologything
(	O
an	O
enzyme	O
)	O
to	O
denature	O
the	O
DNA	other-biologything
.	O

Neuraminidase	other-biologything
is	O
a	O
type	O
of	O
glycoside	other-biologything
hydrolase	other-biologything
enzyme	other-biologything
which	O
helps	O
to	O
move	O
the	O
virus	O
particles	O
through	O
the	O
infected	O
cell	O
and	O
assist	O
in	O
budding	O
from	O
the	O
host	O
cells	O
.	O

Hemoglobin	other-biologything
J	other-biologything
is	O
an	O
abnormal	O
hemoglobin	O
,	O
an	O
alpha	O
globin	O
gene	O
variant	O
and	O
present	O
in	O
various	O
geographic	O
locations	O
.	O

The	O
mechanism	O
behind	O
this	O
experience-dependent	O
demethylation	other-biologything
response	O
was	O
previously	O
not	O
fully	O
understood	O
,	O
with	O
some	O
evidence	O
showing	O
that	O
DNMTs	other-biologything
may	O
be	O
involved	O
in	O
demethylation	other-biologything
.	O

No	O
method	O
eradicates	O
herpes	other-biologything
virus	other-biologything
from	O
the	O
body	O
,	O
but	O
antiviral	O
medications	O
can	O
reduce	O
the	O
frequency	O
,	O
duration	O
,	O
and	O
severity	O
of	O
outbreaks	O
.	O

By	O
the	O
time	O
the	O
baby	O
is	O
one	O
year	O
old	O
,	O
the	O
proportions	O
of	O
different	O
types	O
of	O
hemoglobin	O
are	O
expected	O
to	O
approximate	O
the	O
adult	O
levels	O
,	O
with	O
hemoglobin	other-biologything
F	other-biologything
reduced	O
to	O
very	O
low	O
levels	O
.	O

CCR5	other-biologything
co-receptor	O
antagonists	O
prevent	O
HIV-1	other-biologything
from	O
entering	O
and	O
infecting	O
immune	O
cells	O
by	O
blocking	O
CCR5	other-biologything
cell-surface	O
receptor	O
.	O

Kal-7-dependent	other-biologything
regulation	O
of	O
spine	O
formation	O
occurs	O
through	O
its	O
activity	O
as	O
a	O
GDP	other-biologything
/	O
GTP	other-biologything
exchange	O
factor	O
for	O
Rac1	other-biologything
.	O

Hyaluronidases	other-biologything
intracellularly	O
degrade	O
hyaluronan	other-biologything
,	O
one	O
of	O
the	O
major	O
glycosaminoglycans	other-biologything
of	O
the	O
extracellular	other-biologything
matrix	other-biologything
.	O

The	O
activity	O
of	O
E.	other-biologything
coli	other-biologything
DNA	other-biologything
ligase	other-biologything
can	O
be	O
enhanced	O
by	O
DNA	other-biologything
polymerase	other-biologything
at	O
the	O
right	O
concentrations	O
.	O

Methylobacterium	other-biologything
organophilum	O
is	O
a	O
facultatively	O
methylotrophic	O
bacteria	O
from	O
the	O
genus	O
of	O
Methylobacterium	other-biologything
which	O
was	O
isolated	O
from	O
sediments	O
from	O
the	O
Lake	O
Mendota	O
in	O
Madison	O
in	O
the	O
United	O
States	O
.	O

Promyelocytic	O
leukemia	O
protein	O
(	O
PML	other-biologything
)	O
(	O
also	O
known	O
as	O
MYL	other-biologything
,	O
RNF71	other-biologything
,	O
PP8675	other-biologything
or	O
TRIM19	other-biologything
)	O
is	O
the	O
protein	O
product	O
of	O
the	O
PML	other-biologything
gene	O
.	O

It	O
will	O
cause	O
β-catenin	other-biologything
to	O
translocate	O
to	O
the	O
nucleus	O
without	O
any	O
external	O
stimulus	O
and	O
continuously	O
drive	O
transcription	O
of	O
its	O
target	O
genes	O
.	O

DNA	other-biologything
labeling	O
can	O
be	O
used	O
in	O
conjunction	O
with	O
neuronal	O
lineage	O
markers	O
to	O
determine	O
the	O
fate	O
of	O
new	O
functional	O
brain	O
cells	O
.	O

Other	O
pro-degeneration	O
signaling	O
pathways	O
,	O
such	O
as	O
the	O
MAP	other-biologything
kinase	O
pathway	O
,	O
have	O
been	O
linked	O
to	O
SARM1	other-biologything
activation	O
.	O

It	O
may	O
also	O
be	O
connected	O
to	O
lessened	O
immune	O
function	O
based	O
on	O
studies	O
reporting	O
lower	O
levels	O
of	O
salivary	O
Immunoglobulin	other-biologything
A	other-biologything
in	O
adult	O
women	O
following	O
tears	O
but	O
not	O
sadness	O
alone	O
.	O

MAP	other-biologything
kinase	other-biologything
and	O
Akt	other-biologything
are	O
involved	O
in	O
inhibition	O
of	O
apoptosis	O
,	O
and	O
it	O
has	O
been	O
demonstrated	O
that	O
progestin	O
activates	O
MAP	O
kinase	O
and	O
Akt	O
through	O
mPRs	O
.	O

For	O
Thiamin	other-biologything
and	O
Niacin	other-biologything
the	O
PRIs	O
are	O
expressed	O
as	O
amounts	O
per	O
MJ	O
of	O
calories	O
consumed	O
.	O

TP53	other-biologything
mutations	O
have	O
also	O
been	O
expressed	O
in	O
cells	O
that	O
exhibit	O
shorter	O
and	O
are	O
more	O
end-end	O
fusion	O
prone	O
.	O

HS	other-biologything
synthesis	O
initiates	O
with	O
the	O
transfer	O
of	O
xylose	other-biologything
from	O
UDP-xylose	other-biologything
by	O
xylosyltransferase	other-biologything
(	O
XT	other-biologything
)	O
to	O
specific	O
serine	O
residues	O
within	O
the	O
protein	O
core	O
.	O

Enhancement	O
only	O
works	O
when	O
the	O
concentrations	O
of	O
the	O
DNA	other-biologything
polymerase	other-biologything
1	other-biologything
are	O
much	O
lower	O
than	O
the	O
DNA	other-biologything
fragments	other-biologything
to	O
be	O
ligated	O
.	O

A	O
compositional	O
bias	O
of	O
Glutamic	other-biologything
acid	other-biologything
can	O
be	O
found	O
between	O
residues	O
307	O
and	O
316	O
.	O

Glutamic	other-biologything
acid	other-biologything
is	O
produced	O
on	O
the	O
largest	O
scale	O
of	O
any	O
amino	O
acid	O
,	O
with	O
an	O
estimated	O
annual	O
production	O
of	O
about	O
1.5	O
million	O
tons	O
in	O
2006	O
.	O

The	O
core	O
of	O
the	O
complex	O
is	O
structurally	O
similar	O
to	O
cytochrome	other-biologything
bc1	other-biologything
core	O
.	O

The	O
level	O
of	O
Immunoglobulin	other-biologything
A	other-biologything
(	O
IgA	other-biologything
)	O
in	O
breast	O
milk	O
remains	O
high	O
from	O
day	O
10	O
until	O
at	O
least	O
7.5	O
months	O
post-partum	O
.	O

Fibrin	other-biologything
scaffold	O
has	O
many	O
aspects	O
like	O
being	O
biocompatible	O
,	O
biodegradable	O
and	O
easily	O
processable	O
.	O

HMGB1	other-biologything
is	O
an	O
intracellular	O
DNA	other-biologything
-binding	O
protein	O
important	O
in	O
chromatin	other-biologything
remodeling	O
which	O
can	O
be	O
released	O
by	O
necrotic	O
cells	O
passively	O
,	O
and	O
by	O
active	O
secretion	O
from	O
macrophages	O
,	O
natural	O
killer	O
cells	O
,	O
and	O
dendritic	O
cells	O
.	O

FADD	other-biologything
is	O
involved	O
in	O
the	O
activation	O
of	O
the	O
phosphatases	O
which	O
dephosphorylate	O
and	O
deactivate	O
Protein	other-biologything
Kinase	other-biologything
C	other-biologything
(	O
PKC	other-biologything
)	O
.	O

Animal	O
and	O
human	O
data	O
have	O
revealed	O
evidence	O
of	O
lethal	O
harm	O
to	O
the	O
embryo	O
and	O
teratogenicity	O
associated	O
with	O
ACE	other-biologything
inhibitors	O
.	O

During	O
cell	O
division	O
,	O
FtsZ	other-biologything
is	O
the	O
first	O
protein	O
to	O
move	O
to	O
the	O
division	O
site	O
,	O
and	O
is	O
essential	O
for	O
recruiting	O
other	O
proteins	O
that	O
produce	O
a	O
new	O
cell	O
wall	O
(	O
septum	O
)	O
between	O
the	O
dividing	O
cells	O
.	O

Higher	O
concentrations	O
of	O
SYBR	O
Green	O
can	O
be	O
used	O
to	O
stain	O
agarose	O
gels	O
in	O
order	O
to	O
visualise	O
the	O
DNA	other-biologything
present	O
.	O

In	O
order	O
to	O
be	O
active	O
,	O
most	O
CDKs	other-biologything
require	O
not	O
only	O
a	O
cyclin	O
partner	O
but	O
also	O
phosphorylation	O
at	O
one	O
particular	O
site	O
,	O
which	O
corresponds	O
to	O
Thr161	other-biologything
in	O
human	O
CDK1	other-biologything
,	O
and	O
which	O
is	O
located	O
within	O
the	O
so-called	O
T-loop	other-biologything
(	O
or	O
activation	O
loop	O
)	O
of	O
kinase	O
subdomain	O
VIII	O
.	O

The	O
Polycomb	other-biologything
Repressive	other-biologything
Complex	other-biologything
1	other-biologything
(	O
PRC	other-biologything
1	other-biologything
)	O
is	O
directly	O
involved	O
in	O
the	O
process	O
of	O
hematopoiesis	O
,	O
and	O
functions	O
together	O
with	O
,	O
for	O
example	O
,	O
the	O
PcG	other-biologything
gene	O
“	O
Bmi1	other-biologything
”	O
.	O

This	O
was	O
shown	O
by	O
measuring	O
lymphocyte	O
response	O
to	O
the	O
foreign	O
mitogens	O
phytohaemagglutinin	other-biologything
(	O
PHA	other-biologything
)	O
and	O
concanavalin	other-biologything
A	other-biologything
(	O
ConA	other-biologything
)	O
just	O
prior	O
to	O
and	O
6	O
weeks	O
after	O
writing	O
.	O

Growth	O
hormone	O
,	O
also	O
called	O
somatotropin	other-biologything
,	O
is	O
a	O
polypeptide	other-biologything
hormone	other-biologything
which	O
stimulates	O
growth	O
and	O
cell	O
reproduction	O
.	O

Glutamine	other-biologything
synthetase	other-biologything
uses	O
ammonia	other-biologything
produced	O
by	O
nitrate	O
reduction	O
,	O
amino	other-biologything
acid	other-biologything
degradation	O
,	O
and	O
photorespiration	O
.	O

MAP	other-biologything
kinases	other-biologything
,	O
also	O
known	O
as	O
extracellular	other-biologything
signal-regulated	other-biologything
kinases	other-biologything
(	O
ERKs	other-biologything
)	O
,	O
act	O
as	O
an	O
integration	O
point	O
for	O
multiple	O
biochemical	O
signals	O
.	O

It	O
can	O
take	O
place	O
on	O
several	O
amino	other-biologything
acids	other-biologything
,	O
like	O
lysine	other-biologything
,	O
asparagine	other-biologything
,	O
aspartate	other-biologything
and	O
histidine	other-biologything
,	O
but	O
the	O
most	O
frequently	O
hydroxylated	O
amino	other-biologything
acid	other-biologything
residue	O
in	O
human	O
proteins	O
is	O
proline	other-biologything
.	O

This	O
heterochromatin	O
greatly	O
reduces	O
,	O
if	O
not	O
completely	O
silences	O
gene	O
expression	O
of	O
the	O
Barr	other-biologything
body	other-biologything
.	O

SHH	other-biologything
binds	O
to	O
the	O
Patched	O
receptor	O
which	O
in	O
the	O
absence	O
of	O
SHH	other-biologything
inhibits	O
the	O
Smoothened	O
receptor	O
.	O

GSK3β	other-biologything
is	O
negatively	O
controlled	O
by	O
the	O
PI3K	other-biologything
pathway	O
in	O
form	O
of	O
phosphorylation	O
,	O
which	O
is	O
one	O
of	O
several	O
ways	O
in	O
which	O
growth	O
factors	O
regulate	O
cyclin	other-biologything
D	other-biologything
.	O
Amount	O
of	O
cyclin	other-biologything
D	other-biologything
in	O
the	O
cell	O
can	O
also	O
be	O
regulated	O
by	O
transcriptional	O
induction	O
,	O
stabilization	O
of	O
the	O
protein	O
,	O
its	O
translocation	O
to	O
the	O
nucleus	O
and	O
its	O
assembly	O
with	O
Cdk4	other-biologything
and	O
Cdk6	other-biologything
.	O

RNA	other-biologything
replication	O
is	O
the	O
copying	O
of	O
one	O
RNA	other-biologything
to	O
another	O
.	O

A	O
leaf-eating	other-biologything
caterpillar	other-biologything
and	O
the	O
green	other-biologything
slug	other-biologything
caterpillar	other-biologything
attack	O
the	O
foliage	O
.	O

Mdm2	other-biologything
is	O
capable	O
of	O
auto-polyubiquitination	O
,	O
and	O
in	O
complex	O
with	O
p300	O
,	O
a	O
cooperating	O
E3	other-biologything
ubiquitin	other-biologything
ligase	other-biologything
,	O
is	O
capable	O
of	O
polyubiquitinating	other-biologything
p53	other-biologything
.	O

The	O
most	O
common	O
and	O
well-studied	O
example	O
is	O
RNA	other-biologything
interference	other-biologything
(	O
RNAi	other-biologything
)	O
,	O
in	O
which	O
endogenously	O
expressed	O
microRNA	other-biologything
(	O
miRNA	other-biologything
)	O
or	O
exogenously	O
derived	O
small	other-biologything
interfering	other-biologything
RNA	other-biologything
(	O
siRNA	other-biologything
)	O
induces	O
the	O
degradation	O
of	O
complementary	O
messenger	O
RNA	other-biologything
.	O

These	O
fibrils	O
deposit	O
outside	O
neurons	O
in	O
dense	O
formations	O
known	O
as	O
senile	O
plaques	O
or	O
neuritic	O
plaques	O
,	O
in	O
less	O
dense	O
aggregates	O
as	O
``	O
diffuse	O
plaques	O
''	O
,	O
and	O
sometimes	O
in	O
the	O
walls	O
of	O
small	O
blood	O
vessels	O
in	O
the	O
brain	other-biologything
in	O
a	O
process	O
called	O
cerebral	O
amyloid	O
angiopathy	O
.	O

It	O
is	O
used	O
to	O
cultivate	O
dermatophytes	O
and	O
other	O
types	O
of	O
fungi	O
,	O
and	O
can	O
also	O
grow	O
filamentous	O
bacteria	O
such	O
as	O
``	O
Nocardia	other-biologything
``	O
.	O

The	O
archaeal	O
pre-RC	other-biologything
is	O
very	O
different	O
from	O
the	O
bacterial	O
pre-RC	other-biologything
and	O
can	O
serve	O
as	O
a	O
simplified	O
model	O
of	O
the	O
eukaryotic	O
pre-RC	other-biologything
.	O

Additionally	O
,	O
a	O
partial	O
decrease	O
of	O
STAT1	other-biologything
activation	O
likely	O
participates	O
in	O
immune	O
deficiencies	O
.	O

One	O
nucleotide	other-biologything
contains	O
an	O
adenine	other-biologything
nucleobase	other-biologything
and	O
the	O
other	O
nicotinamide	other-biologything
.	O

KCNE3	other-biologything
is	O
best	O
known	O
for	O
modulating	O
the	O
KCNQ1	other-biologything
Kv	other-biologything
α	other-biologything
subunit	O
,	O
but	O
it	O
also	O
regulates	O
hERG	other-biologything
,	O
Kv2.1	other-biologything
,	O
Kv3.x	other-biologything
,	O
Kv4.x	other-biologything
and	O
Kv12.2	other-biologything
in	O
heterologous	O
co-expression	O
experiments	O
and/or	O
in	O
vivo	O
.	O

The	O
first	O
estrogen	other-biologything
ester	O
to	O
be	O
marketed	O
was	O
estradiol	other-biologything
benzoate	other-biologything
in	O
1933	O
,	O
which	O
was	O
followed	O
by	O
many	O
more	O
.	O

This	O
obviated	O
adding	O
new	O
DNA	O
polymerase	O
after	O
each	O
PCR	other-biologything
cycle	O
,	O
thus	O
greatly	O
simplifying	O
DNA	O
mutagenesis	O
and	O
assembly	O
.	O

FTL	other-biologything
is	O
regulated	O
by	O
iron	O
and	O
with	O
an	O
increase	O
in	O
iron	O
,	O
there	O
is	O
both	O
an	O
increase	O
in	O
the	O
FTL	other-biologything
expression	O
and	O
PEN-2	other-biologything
levels	O
,	O
which	O
results	O
in	O
increased	O
γ-	other-biologything
secretase	other-biologything
activity	O
.	O

Though	O
physiologically	O
irrelevant	O
,	O
homotetrameric	O
Kv7.1	other-biologything
channels	O
also	O
display	O
a	O
unique	O
form	O
of	O
C-type	O
inactivation	O
that	O
reaches	O
equilibrium	O
quickly	O
,	O
allowing	O
KvLQT1	other-biologything
currents	O
to	O
plateau	O
.	O

ATP	other-biologything
synthase	other-biologything
F1	other-biologything
subunit	other-biologything
beta	other-biologything
,	O
mitochondrial	other-biologything
is	O
an	O
enzyme	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	other-biologything
ATP5F1B	other-biologything
''	other-biologything
gene	other-biologything
.	O

This	O
methylation	O
damages	O
the	O
DNA	other-biologything
and	O
triggers	O
the	O
death	O
of	O
tumor	O
cells	O
.	O

The	O
interaction	O
between	O
GAB2	other-biologything
and	O
Grb2	other-biologything
requires	O
a	O
PX3RX2KP	O
motif	O
in	O
order	O
to	O
produce	O
a	O
regulatory	O
signal	O
.	O

[	O
...	O
]	O
When	O
the	O
researchers	O
looked	O
at	O
how	O
existing	O
drugs	O
interacted	O
with	O
the	O
N1	other-biologything
protein	O
,	O
they	O
found	O
that	O
,	O
in	O
the	O
presence	O
of	O
neuraminidase	other-biologything
inhibitors	O
,	O
the	O
loop	O
changed	O
its	O
conformation	O
to	O
one	O
similar	O
to	O
that	O
in	O
the	O
N2	other-biologything
and	O
N9	other-biologything
proteins	O
.	O
''	O

Yeast	other-biologything
Hsp90	other-biologything
is	O
60	O
%	O
identical	O
to	O
human	O
Hsp90α	other-biologything
.	O

In	O
some	O
cell	O
types	O
,	O
however	O
,	O
full-length	O
ARF	other-biologything
can	O
also	O
localize	O
to	O
the	O
mitochondria	other-biologything
and	O
induce	O
type	other-biologything
II	other-biologything
cell	other-biologything
death	O
,	O
suggesting	O
that	O
in	O
addition	O
to	O
autophagy	O
being	O
a	O
starvation	O
or	O
other	O
environmental	O
response	O
,	O
it	O
may	O
also	O
be	O
involved	O
in	O
responding	O
to	O
oncogene	O
activation	O
.	O

It	O
is	O
known	O
to	O
induce	O
inflammation	O
by	O
activating	O
NF-kB	other-biologything
pathway	O
by	O
binding	O
to	O
TLR	other-biologything
,	O
TLR4	other-biologything
,	O
TLR9	other-biologything
,	O
and	O
RAGE	other-biologything
(	O
receptor	O
for	O
advanced	O
glycation	O
end	O
products	O
)	O
.	O

the	O
rate	O
at	O
which	O
it	O
converts	O
L-tryptophan	other-biologything
into	O
the	O
serotonin	other-biologything
precursor	other-biologything
L-5-hydroxytryptophan	other-biologything
)	O
can	O
be	O
increased	O
when	O
it	O
undergoes	O
phosphorylation	other-biologything
.	O

IAS	other-biologything
proteins	O
were	O
originally	O
identified	O
in	O
studies	O
that	O
were	O
aimed	O
to	O
decipher	O
the	O
Janus	other-biologything
Kinase	other-biologything
(	O
JAK	other-biologything
)	O
/	O
STAT	other-biologything
signaling	O
pathway	O
.	O

The	O
manufacturing	O
process	O
uses	O
hydrolysis	O
via	O
pressurized	O
steaming	O
at	O
controlled	O
pH	O
in	O
a	O
jet	O
followed	O
by	O
further	O
enzymatic	other-biologything
depolymerization	other-biologything
.	O

HOTAIR	other-biologything
is	O
highly	O
expressed	O
in	O
primary	O
breast	O
tumors	O
.	O

Since	O
then	O
,	O
approximately	O
43	O
hantavirus	O
strains	O
,	O
of	O
which	O
20	O
are	O
pathogenic	O
,	O
have	O
been	O
found	O
in	O
the	O
Americas	O
and	O
are	O
referred	O
to	O
as	O
the	O
New	other-biologything
World	other-biologything
hantaviruses	other-biologything
.	O

Some	O
data	O
from	O
``	O
in	O
vitro	O
''	O
and	O
animal	O
studies	O
suggested	O
that	O
fatty	O
acid	O
uptake	O
through	O
CD36	other-biologything
may	O
promote	O
cancer	O
cell	O
migration	O
and	O
proliferation	O
in	O
hepatocellular	O
carcinoma	other-biologything
,	O
glioblastoma	other-biologything
,	O
and	O
potentially	O
other	O
cancers	O
;	O
there	O
was	O
limited	O
data	O
from	O
observational	O
studies	O
in	O
people	O
that	O
low	O
CD36	other-biologything
may	O
correlate	O
with	O
a	O
slightly	O
better	O
outcome	O
in	O
glioblastoma	other-biologything
.	O

After	O
the	O
binding	O
of	O
TGF-β	other-biologything
,	O
the	O
type	O
2	O
receptor	O
kinase	O
phosphorylates	O
and	O
activates	O
the	O
type	O
1	O
receptor	O
kinase	O
that	O
activates	O
a	O
signaling	O
cascade	O
.	O

A	O
local	O
increase	O
in	O
concentration	O
of	O
TNF	other-biologything
will	O
cause	O
the	O
cardinal	O
signs	O
of	O
Inflammation	O
to	O
occur	O
:	O
heat	O
,	O
swelling	O
,	O
redness	O
,	O
pain	O
and	O
loss	O
of	O
function	O
.	O

The	O
family	O
Aeolidiidae	other-biologything
,	O
as	O
well	O
as	O
other	O
Nudibranchia	other-biologything
families	O
,	O
are	O
often	O
studied	O
for	O
their	O
adaptable	O
defense	O
from	O
the	O
stinging	O
nematocyst	O
discharge	O
of	O
Cnidarian	other-biologything
sea	other-biologything
anemones	other-biologything
in	O
particular	O
Actinia	other-biologything
,	O
Anemonia	other-biologything
,	O
Metridium	other-biologything
,	O
Sagartia	other-biologything
and	O
Urticina	other-biologything
.	O

Lysine	other-biologything
63-linked	O
polyubiquitination	O
of	O
PCNA	other-biologything
allows	O
it	O
to	O
perform	O
a	O
less	O
error-prone	O
mutation	O
bypass	O
known	O
by	O
the	O
template	O
switching	O
pathway	O
.	O

It	O
was	O
able	O
to	O
potently	O
inhibit	O
80	O
%	O
of	O
muscimol	O
binding	O
to	O
the	O
GABAA	other-biologything
receptor	O
,	O
although	O
it	O
failed	O
to	O
displace	O
the	O
remaining	O
20	O
%	O
of	O
specific	O
muscimol	O
binding	O
.	O

BCL2	other-biologything
family	O
members	O
form	O
oligomers	other-biologything
or	O
heterodimers	other-biologything
and	O
act	O
as	O
anti-	O
or	O
pro-apoptotic	O
regulators	O
that	O
are	O
involved	O
in	O
a	O
wide	O
variety	O
of	O
cellular	O
activities	O
.	O

Upon	O
viral	O
infection	O
,	O
FADD	other-biologything
is	O
needed	O
to	O
increase	O
the	O
levels	O
of	O
Irf7	other-biologything
a	O
molecule	O
which	O
is	O
needed	O
for	O
the	O
production	O
of	O
IFN-α	other-biologything
.	O

It	O
has	O
been	O
estimated	O
that	O
approximately	O
10	O
%	O
of	O
all	O
tissue	O
samples	O
sequenced	O
from	O
all	O
cancers	O
display	O
mutations	O
in	O
the	O
CTNNB1	other-biologything
gene	other-biologything
.	O

Genes	O
that	O
are	O
mutated	O
in	O
all	O
three	O
of	O
these	O
syndromes	O
encode	O
proteins	O
that	O
function	O
in	O
the	O
MAP	other-biologything
kinase	other-biologything
pathway	O
.	O

As	O
a	O
result	O
of	O
suppression	O
of	O
healthy	O
bacteria	O
,	O
via	O
a	O
loss	O
of	O
bacterial	O
food	O
source	O
,	O
prolonged	O
use	O
of	O
an	O
elemental	O
diet	O
increases	O
the	O
risk	O
of	O
developing	O
``	O
C.	other-biologything
difficile	other-biologything
``	O
infection	O
.	O

It	O
has	O
been	O
found	O
to	O
inhibit	O
p300	other-biologything
and	O
CREB-binding	other-biologything
protein	other-biologything
(	O
CBP	other-biologything
)	O
,	O
which	O
are	O
epigenetic	O
regulators	O
that	O
control	O
the	O
levels	O
of	O
proteins	O
that	O
cause	O
inflammation	O
or	O
are	O
involved	O
in	O
cell	O
growth	O
.	O

ALT	other-biologything
is	O
used	O
in	O
a	O
second	O
assessment	O
called	O
ActiTest	O
that	O
is	O
part	O
of	O
FibroTest	O
.	O

Other	O
disorders	O
:	O
Several	O
variations	O
of	O
the	O
HLA-B	other-biologything
gene	O
are	O
associated	O
with	O
adverse	O
reactions	O
to	O
certain	O
drugs	O
.	O

If	O
damaged	O
DNA	other-biologything
is	O
left	O
unrepaired	O
,	O
it	O
can	O
lead	O
to	O
cell	O
death	O
or	O
genomic	O
instability	O
,	O
cancer	O
and	O
other	O
pathologies	O
.	O

PRC2	other-biologything
acts	O
to	O
create	O
heterochromatin	other-biologything
in	O
these	O
regions	O
through	O
similar	O
mechanisms	O
to	O
the	O
mechanism	O
used	O
to	O
repress	O
genes	O
.	O

The	O
protein	O
encoded	O
by	O
this	O
gene	O
forms	O
a	O
complex	O
with	O
two	O
other	O
proteins	O
,	O
NPL4	other-biologything
and	O
VCP	other-biologything
,	O
that	O
is	O
necessary	O
for	O
the	O
degradation	O
of	O
ubiquitinated	O
proteins	O
.	O

When	O
found	O
in	O
nature	O
,	O
``	O
Francisella	other-biologything
tularensis	other-biologything
``	O
can	O
survive	O
for	O
several	O
weeks	O
at	O
low	O
temperatures	O
in	O
animal	O
carcasses	O
,	O
soil	O
,	O
and	O
water	O
.	O

The	O
iPGM	other-biologything
(	O
)	O
class	O
is	O
found	O
in	O
all	O
plants	O
and	O
algae	O
as	O
well	O
as	O
in	O
some	O
invertebrate	other-biologything
,	O
fungi	other-biologything
,	O
and	O
Gram-positive	other-biologything
bacteria	other-biologything
.	O

Mortality	O
related	O
to	O
``	O
C	other-biologything
.	other-biologything
``	O
``	O
tertium	other-biologything
``	O
bacteremia	O
treated	O
appropriately	O
appears	O
to	O
be	O
quite	O
low	O
.	O

Another	O
way	O
in	O
which	O
DNA	other-biologything
damage	O
targets	O
Cdks	other-biologything
is	O
p53	other-biologything
-dependent	O
induction	O
of	O
p21	other-biologything
,	O
which	O
inhibits	O
cyclin	other-biologything
E-Cdk2	other-biologything
complex	O
.	O

PZ	other-biologything
neurons	O
are	O
also	O
believed	O
to	O
be	O
sleep	O
active	O
,	O
as	O
they	O
express	O
c-Fos	O
after	O
sleep	O
but	O
not	O
after	O
wakefulness	O
.	O

Due	O
to	O
the	O
COVID-19	other-biologything
pandemic	O
,	O
all	O
matches	O
during	O
the	O
2020–21	O
season	O
will	O
be	O
played	O
behind-closed-doors	O
across	O
three	O
venues	O
in	O
Goa	O
.	O

For	O
example	O
,	O
most	O
adult	O
cells	O
in	O
mice	O
proliferate	O
normally	O
even	O
without	O
both	O
CDK4	other-biologything
and	O
CDK2	other-biologything
.	O

Fibronectin	other-biologything
has	O
numerous	O
functions	O
that	O
ensure	O
the	O
normal	O
functioning	O
of	O
vertebrate	O
organisms	other-biologything
.	O

``	O
A.	other-biologything
sloanii	other-biologything
``	O
has	O
been	O
cultivated	O
on	O
both	O
Czapek	other-biologything
yeast	other-biologything
extract	other-biologything
agar	other-biologything
(	O
CYA	other-biologything
)	O
plates	O
and	O
yeast	other-biologything
extract	other-biologything
sucrose	other-biologything
agar	other-biologything
(	O
YES	other-biologything
)	O
plates	O
.	O

CikA	other-biologything
is	O
a	O
major	O
factor	O
in	O
the	O
input	O
pathway	O
and	O
causes	O
KaiC	other-biologything
dependent	O
cell	O
elongation	O
.	O

While	O
TrkB	other-biologything
mediates	O
the	O
effects	O
of	O
BDNF	other-biologything
,	O
NT-4	other-biologything
and	O
NT-3	other-biologything
,	O
TrkA	other-biologything
is	O
bound	O
and	O
thereby	O
activated	O
only	O
by	O
NGF	other-biologything
.	O

Catecholamine	other-biologything
secretion	O
from	O
chromaffin	other-biologything
cells	other-biologything
is	O
particularly	O
sensitive	O
to	O
L-type	O
currents	O
,	O
associated	O
with	O
Cav1.3	other-biologything
.	O

Yersinia	other-biologything
pestis	other-biologything
(	O
formerly	O
``	O
Pasteurella	other-biologything
pestis	other-biologything
``	O
)	O
is	O
a	O
gram-negative	O
,	O
non-motile	O
,	O
rod-shaped	O
,	O
coccobacillus	other-biologything
bacterium	other-biologything
,	O
without	O
spores	O
.	O

Activated	O
TGF-β	other-biologything
complexes	O
with	O
other	O
factors	O
to	O
form	O
a	O
serine/threonine	O
kinase	O
complex	O
that	O
binds	O
to	O
TGF-β	other-biologything
receptors	O
.	O

In	O
the	O
laboratory	O
,	O
``	O
F.	other-biologything
tularensis	other-biologything
``	O
appears	O
as	O
small	O
rods	O
(	O
0.2	O
by	O
0.2	O
µm	O
)	O
,	O
and	O
is	O
grown	O
best	O
at	O
35–37	O
°C	O
.	O

LecRK-1.8	other-biologything
has	O
been	O
reported	O
to	O
recognize	O
extracellular	O
NAD	other-biologything
molecules	O
and	O
LecRK-1.9	other-biologything
has	O
been	O
reported	O
to	O
recognize	O
extracellular	O
ATP	other-biologything
molecules	O
.	O

These	O
Treg	other-biologything
abnormalities	O
likely	O
play	O
a	O
major	O
role	O
in	O
autoimmunity	O
,	O
although	O
some	O
patients	O
with	O
normal	O
Tregs	other-biologything
also	O
presented	O
with	O
autoimmunity	O
disorders	O
.	O

Transketolase	other-biologything
and	O
transaldolase	other-biologything
convert	O
two	O
molecules	O
of	O
F6P	other-biologything
and	O
one	O
molecule	O
of	O
G3P	other-biologything
to	O
three	O
molecules	O
of	O
R5P	other-biologything
.	O

DLC1	other-biologything
also	O
performs	O
a	O
second	O
pro-apoptotic	O
function	O
:	O
it	O
reduces	O
cellular	O
levels	O
of	O
the	O
anti-apoptotic	O
protein	O
Bcl-2	other-biologything
.	O

As	O
such	O
,	O
it	O
can	O
not	O
be	O
crystallized	O
and	O
most	O
structural	O
knowledge	O
on	O
amyloid	other-biologything
beta	other-biologything
comes	O
from	O
NMR	O
and	O
molecular	O
dynamics	O
.	O

The	O
``	O
CNN2	other-biologything
``	O
gene	O
is	O
located	O
at	O
19p13.3	O
in	O
the	O
human	O
chromosomal	O
genome	O
,	O
encoding	O
the	O
protein	O
calponin	other-biologything
2	other-biologything
.	O

The	O
significantly	O
increased	O
lymphocyte	other-biologything
response	O
led	O
to	O
speculation	O
that	O
expressive	O
writing	O
enhances	O
immunocompetence	O
.	O

Further	O
coordination	O
is	O
required	O
during	O
DNA	other-biologything
replication	O
.	O

In	O
the	O
1970s	O
,	O
testosterone	other-biologything
undecanoate	O
was	O
introduced	O
for	O
oral	O
use	O
in	O
Europe	O
,	O
although	O
intramuscular	O
testosterone	other-biologything
undecanoate	O
had	O
already	O
been	O
in	O
use	O
in	O
China	O
for	O
several	O
years	O
.	O

With	O
``	O
20	O
of	O
the	O
21	O
podium	O
finishers	O
in	O
the	O
Tour	O
de	O
France	O
from	O
1999	O
through	O
2005	O
directly	O
tied	O
to	O
likely	O
doping	O
through	O
admissions	O
,	O
sanctions	O
,	O
public	O
investigations	O
or	O
exceeding	O
the	O
UCI	other-biologything
hematocrit	other-biologything
(	O
a	O
blood	O
test	O
to	O
discover	O
EPO	other-biologything
use	O
)	O
threshold	O
''	O
,	O
Escartin	O
's	O
third-place	O
finish	O
in	O
the	O
1999	O
Tour	O
de	O
France	O
stands	O
as	O
the	O
lone	O
of	O
the	O
21	O
podium	O
finishes	O
that	O
was	O
untainted	O
,	O
during	O
the	O
years	O
(	O
1999–2005	O
)	O
in	O
which	O
Lance	O
Armstrong	O
finished	O
the	O
Tour	O
de	O
France	O
in	O
first	O
place	O
.	O

Both	O
CRL4	other-biologything
complexes	other-biologything
utilize	O
Cdt2	other-biologything
and	O
the	O
DNA	other-biologything
processivity	O
factor	O
PCNA	other-biologything
to	O
induce	O
the	O
ubiquitination	O
and	O
degradation	O
of	O
replication	O
licensing	O
factor	O
Cdt1	other-biologything
and	O
cyclin-dependent	O
kinase	O
inhibitor	O
p21	other-biologything
in	O
a	O
proteasome-dependent	O
manner	O
.	O

PEBP	other-biologything
,	O
or	O
Raf	other-biologything
kinase	other-biologything
inhibitor	other-biologything
protein	other-biologything
(	O
RKIP	other-biologything
)	O
is	O
diminished	O
in	O
paraptotic	other-biologything
cells	other-biologything
,	O
thus	O
resultant	O
down	O
regulation	O
of	O
PEBP	other-biologything
and/or	O
other	O
kinase	other-biologything
inhibitors	other-biologything
seem	O
to	O
indicate	O
participation	O
in	O
the	O
MAPK	other-biologything
and	O
JNK	other-biologything
pathways	O
,	O
as	O
diminished	O
PEBP	other-biologything
would	O
allow	O
for	O
the	O
levels	O
of	O
MAPK	other-biologything
and	O
JNK	other-biologything
to	O
accumulate	O
enough	O
to	O
be	O
sufficient	O
to	O
induce	O
cell	O
death	O
.	O

HePTP	other-biologything
is	O
expressed	O
in	O
all	O
leukocytes	other-biologything
.	O

Thus	O
,	O
HBB	other-biologything
mutants	O
are	O
the	O
sources	O
of	O
positive	O
selection	O
in	O
these	O
regions	O
and	O
are	O
important	O
for	O
their	O
long-term	O
survival	O
.	O

Burkholderia	other-biologything
plantarii	other-biologything
is	O
a	O
Gram-negative	O
soil	O
bacterium	O
.	O

However	O
,	O
the	O
structure	O
of	O
DNA	other-biologything
polymerases	other-biologything
does	O
not	O
allow	O
a	O
continuous	O
stable	O
interaction	O
with	O
the	O
template	other-biologything
DNA	other-biologything
.	O

Neural	other-biologything
retina-specific	other-biologything
leucine	other-biologything
zipper	other-biologything
protein	other-biologything
is	O
a	O
protein	other-biologything
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
NRL	other-biologything
``	O
gene	O
.	O

The	O
first	O
step	O
in	O
the	O
assembly	O
of	O
the	O
pre-replication	O
complex	O
(	O
pre-	O
RC	other-biologything
)	O
is	O
the	O
binding	O
of	O
the	O
origin	O
recognition	O
complex	O
(	O
ORC	other-biologything
)	O
to	O
the	O
replication	O
origin	O
.	O

Other	O
names	O
in	O
common	O
use	O
include	O
pyridoxine	other-biologything
5-phosphate	other-biologything
phospho	other-biologything
lyase	other-biologything
,	O
PNP	other-biologything
synthase	other-biologything
,	O
and	O
PdxJ	other-biologything
.	O

This	O
complex	O
is	O
then	O
internalised	O
,	O
and	O
FADD	other-biologything
binds	O
to	O
TRADD	other-biologything
via	O
an	O
interaction	O
of	O
the	O
DD	other-biologything
’	O
s	O
of	O
the	O
two	O
adapter	O
proteins	O
,	O
forming	O
what	O
is	O
known	O
as	O
complex	O
II	O
.	O

Protein	other-biologything
A	other-biologything
contains	O
five	O
highly	O
homologous	O
immunoglobulin	other-biologything
(	O
Ig	other-biologything
)	O
-binding	O
domains	O
in	O
tandem	O
(	O
designated	O
domains	O
E	O
,	O
D	O
,	O
A	O
,	O
B	O
and	O
C	O
)	O
,	O
which	O
share	O
a	O
common	O
structure	O
consisting	O
of	O
three	O
helices	other-biologything
in	O
a	O
closed	O
left-handed	O
twist	O
.	O

Binding	O
and	O
activation	O
of	O
the	O
receptor	O
stimulates	O
Janus	other-biologything
protein	other-biologything
kinases	other-biologything
,	O
which	O
in	O
turn	O
phosphorylate	O
several	O
proteins	O
,	O
including	O
STAT1	other-biologything
and	O
STAT2	other-biologything
.	O

POLB	other-biologything
gene	O
expression	O
is	O
also	O
regulated	O
at	O
the	O
post	O
transcriptional	O
level	O
as	O
the	O
3	other-biologything
’	other-biologything
UTR	other-biologything
of	O
the	O
POLB	other-biologything
mRNA	other-biologything
has	O
been	O
shown	O
to	O
contain	O
three	O
stem-loop	O
structures	O
that	O
influence	O
gene	O
expression	O
.	O

VEGFR-2	other-biologything
is	O
closely	O
related	O
to	O
VEGFR-1	other-biologything
for	O
they	O
have	O
common	O
and	O
specific	O
ligands	O
but	O
VEGFR-2	other-biologything
is	O
a	O
highly	O
active	O
kinase	O
while	O
VEGFR1	other-biologything
is	O
an	O
impaired	O
receptor	other-biologything
tyrosine	other-biologything
kinase	other-biologything
.	O

Misexpressing	O
``	O
Shh	other-biologything
``	O
or	O
``	O
activin	other-biologything
receptor	other-biologything
IIa	other-biologything
``	O
on	O
the	O
right	O
side	O
randomized	O
heart	O
asymmetry	O
in	O
the	O
chick	O
.	O

Thrombin	other-biologything
is	O
one	O
trigger	O
which	O
can	O
stimulate	O
endothelial-cell	other-biologything
release	O
of	O
P-selectin	other-biologything
and	O
recent	O
studies	O
suggest	O
an	O
additional	O
Ca2+	other-biologything
-independent	O
pathway	O
involved	O
in	O
the	O
release	O
of	O
P-selectin	other-biologything
.	O

Within	O
certain	O
cells	O
the	O
enzyme	O
adenylate	O
cyclase	O
makes	O
cAMP	other-biologything
from	O
ATP	other-biologything
,	O
and	O
typically	O
this	O
reaction	O
is	O
regulated	O
by	O
hormones	O
such	O
as	O
adrenaline	O
or	O
glucagon	O
.	O

Synthesized	O
trpR	other-biologything
monomers	O
associate	O
into	O
dimers	O
.	O

Other	O
names	O
in	O
common	O
use	O
include	O
proton-translocating	other-biologything
ATPase	other-biologything
,	O
yeast	other-biologything
plasma	other-biologything
membrane	other-biologything
-ATPase	other-biologything
,	O
plant	other-biologything
plasma	other-biologything
membrane	other-biologything
-ATPase	other-biologything
,	O
yeast	other-biologything
plasma	other-biologything
membrane	other-biologything
ATPase	other-biologything
,	O
plant	other-biologything
plasma	other-biologything
membrane	other-biologything
ATPase	other-biologything
,	O
and	O
ATP	other-biologything
phosphohydrolase	other-biologything
.	O

The	O
therapeutic	O
benefit	O
of	O
temozolomide	O
depends	O
on	O
its	O
ability	O
to	O
alkylate/methylate	O
DNA	other-biologything
,	O
which	O
most	O
often	O
occurs	O
at	O
the	O
N-7	O
or	O
O-6	O
positions	O
of	O
guanine	O
residues	O
.	O

Due	O
to	O
its	O
role	O
in	O
inhibiting	O
cancer	O
growth	O
,	O
GM3	other-biologything
is	O
a	O
target	O
of	O
cancer	O
treatments	O
.	O

Small	O
molecule	O
antagonists	O
of	O
CCR5	other-biologything
bind	O
to	O
a	O
hydrophobic	O
pocket	O
formed	O
by	O
the	O
transmembrane	O
helices	O
of	O
the	O
CCR5	other-biologything
receptor	O
.	O

This	O
conformational	O
change	O
in	O
the	O
araC	other-biologything
no	O
longer	O
can	O
form	O
a	O
loop	O
,	O
and	O
the	O
linear	O
gene	O
segment	O
promotes	O
RNA	other-biologything
polymerase	O
recruitment	O
to	O
the	O
structural	O
araBAD	other-biologything
region	O
.	O

This	O
enzyme	O
belongs	O
to	O
the	O
family	O
of	O
oxidoreductases	other-biologything
,	O
specifically	O
those	O
acting	O
on	O
the	O
CH-NH	O
group	O
of	O
donors	O
with	O
NAD+	O
or	O
NADP+	O
as	O
acceptor	O
.	O

80	O
%	O
of	O
the	O
MA	O
is	O
derived	O
from	O
platelet	O
function	O
whereas	O
the	O
remaining	O
20	O
%	O
is	O
derived	O
from	O
fibrin	other-biologything
.	O

Vegetative	other-biologything
cells	O
of	O
``	O
C.	O
botulinum	O
''	O
may	O
be	O
ingested	O
.	O

Inactivation	O
of	O
cyclin	other-biologything
D	other-biologything
is	O
triggered	O
by	O
several	O
cyclin-dependent	O
kinase	O
inhibitor	O
protein	O
(	O
CKIs	other-biologything
)	O
like	O
the	O
INK4	other-biologything
family	O
(	O
e.g	O
.	O

The	O
activity	O
of	O
protein	O
C	O
may	O
be	O
down-regulated	O
by	O
reducing	O
the	O
amount	O
either	O
of	O
available	O
thrombomodulin	other-biologything
or	O
of	O
EPCR	other-biologything
.	O

Other	O
classes	O
of	O
small	other-biologything
RNA	other-biologything
have	O
been	O
identified	O
,	O
including	O
piwi-interacting	other-biologything
RNA	other-biologything
(	O
piRNA	other-biologything
)	O
and	O
its	O
subspecies	O
repeat	other-biologything
associated	other-biologything
small	other-biologything
interfering	other-biologything
RNA	other-biologything
(	O
rasiRNA	other-biologything
)	O
.	O

In	O
another	O
study	O
,	O
``	O
Arabidopsis	other-biologything
thaliana	other-biologything
``	O
stromal	other-biologything
proteins	other-biologything
were	O
analyzed	O
to	O
determine	O
the	O
relative	O
abundance	O
of	O
specific	O
N-terminal	O
residues	O
.	O

Like	O
most	O
Pipridae	other-biologything
manakins	other-biologything
are	O
primarily	O
a	O
frugivorous	O
species	O
,	O
though	O
populations	O
of	O
Helmeted	other-biologything
manakins	other-biologything
in	O
gallery	O
forests	O
near	O
Capetinga	O
,	O
Brazil	O
have	O
been	O
documented	O
gleaning	O
and	O
sallying	O
insects	O
.	O

Shortly	O
thereafter	O
,	O
in	O
1937	O
,	O
testosterone	other-biologything
first	O
became	O
commercially	O
available	O
as	O
a	O
pharmaceutical	O
drug	O
in	O
the	O
form	O
of	O
pellets	O
and	O
then	O
in	O
ester	O
form	O
for	O
intramuscular	O
injection	O
as	O
the	O
relatively	O
short-acting	O
testosterone	other-biologything
propionate	O
.	O

The	O
Matrix-2	other-biologything
(	O
M2	other-biologything
)	O
protein	O
is	O
a	O
proton-selective	O
viroporin	O
,	O
integral	O
in	O
the	O
viral	O
envelope	O
of	O
the	O
influenza	other-biologything
A	other-biologything
virus	other-biologything
.	O

During	O
his	O
post-doctoral	O
training	O
,	O
he	O
was	O
involved	O
in	O
the	O
determination	O
of	O
the	O
clathrin	other-biologything
triskelion	other-biologything
structure	O
,	O
one	O
of	O
the	O
first	O
studies	O
combining	O
X-ray	O
crystallography	O
and	O
electron	O
microscopy	O
.	O

One	O
of	O
these	O
gradient-forming	O
systems	O
consists	O
of	O
MinCDE	other-biologything
proteins	other-biologything
(	O
see	O
below	O
)	O
.	O

Little	O
is	O
known	O
about	O
the	O
role	O
plant	O
Epsin	other-biologything
plays	O
in	O
clathrin	other-biologything
coated	O
vesicle	O
formation	O
.	O

Aspartate	other-biologything
carbamoyltransferase	other-biologything
was	O
a	O
much	O
larger	O
molecule	O
than	O
anything	O
solved	O
previously	O
.	O

The	O
cleavages	O
at	O
both	O
Arg306	O
and	O
Arg506	O
diminish	O
the	O
molecule	O
's	O
attraction	O
to	O
Factor	other-biologything
Xa	other-biologything
,	O
and	O
though	O
the	O
first	O
of	O
these	O
sites	O
is	O
slow	O
to	O
be	O
cleaved	O
,	O
it	O
is	O
entirely	O
necessary	O
to	O
the	O
functioning	O
of	O
Factor	other-biologything
V	other-biologything
.	O
Protein	other-biologything
S	other-biologything
aids	O
this	O
process	O
by	O
catalysing	O
the	O
proteolysis	O
at	O
Arg306	O
,	O
in	O
which	O
the	O
A2	O
domain	O
of	O
Factor	other-biologything
V	other-biologything
is	O
dissociated	O
from	O
the	O
rest	O
of	O
the	O
protein	O
.	O

Alanine	other-biologything
is	O
found	O
in	O
a	O
wide	O
variety	O
of	O
foods	O
,	O
but	O
is	O
particularly	O
concentrated	O
in	O
meats	O
.	O

A.	O
papillosa	O
participate	O
in	O
``	O
ingestive	O
conditioning	O
''	O
in	O
which	O
they	O
consume	O
the	O
nematocyst	other-biologything
from	O
their	O
prey	O
in	O
response	O
for	O
predators	O
in	O
the	O
same	O
environment	O
.	O

During	O
rapid	O
cell	O
growth	O
,	O
higher	O
quantities	O
of	O
R5P	other-biologything
and	O
NADPH	other-biologything
are	O
needed	O
for	O
nucleotide	O
and	O
fatty	O
acid	O
synthesis	O
,	O
respectively	O
.	O

Autophosphorylated	O
VEGFR-2	other-biologything
is	O
required	O
for	O
activation	O
of	O
several	O
downstream	O
pathways	O
,	O
which	O
are	O
hyperactivated	O
in	O
some	O
tumors	O
.	O

HIPK2	other-biologything
is	O
a	O
protein	O
that	O
regulates	O
Mdm2	other-biologything
in	O
this	O
way	O
.	O

Gephyrin	other-biologything
,	O
an	O
integral	O
membrane	O
protein	O
believed	O
to	O
coordinate	O
glycine	O
receptors	O
,	O
is	O
coded	O
by	O
the	O
gene	O
GPHN	other-biologything
.	O

The	O
ATP7B	other-biologything
protein	O
is	O
located	O
in	O
the	O
trans-Golgi	O
network	O
of	O
the	O
liver	O
and	O
brain	O
and	O
balances	O
the	O
copper	O
level	O
in	O
the	O
body	O
by	O
excreting	O
excess	O
copper	O
into	O
bile	O
and	O
plasma	O
.	O

Mean	O
corpuscular	other-biologything
hemoglobin	other-biologything
(	O
MCH	other-biologything
)	O
is	O
the	O
average	O
amount	O
of	O
hemoglobin	other-biologything
(	O
Hb	other-biologything
)	O
per	other-biologything
red	other-biologything
blood	other-biologything
cell	other-biologything
and	O
is	O
calculated	O
by	O
dividing	O
the	O
hemoglobin	other-biologything
by	O
the	O
red	other-biologything
blood	other-biologything
cell	other-biologything
count	O
.	O

Zosterornis	other-biologything
is	O
a	O
genus	O
of	O
passerine	O
bird	O
in	O
the	O
Old	O
World	O
babbler	O
family	O
Zosteropidae	other-biologything
(	O
Moyle	O
et	O
al.	O
,	O
2009	O
)	O
,	O
although	O
some	O
taxonomists	O
continue	O
to	O
place	O
the	O
genus	O
in	O
the	O
Old	O
World	O
babbler	O
family	O
Timaliidae	other-biologything
.	O

Purified	O
RNA	other-biologything
of	O
a	O
positive-sense	O
virus	O
can	O
directly	O
cause	O
infection	O
though	O
it	O
may	O
be	O
less	O
infectious	O
than	O
the	O
whole	O
virus	O
particle	O
.	O

Mcr7	other-biologything
sRNA	other-biologything
encoded	O
by	O
the	O
``	O
mcr7	other-biologything
``	O
gene	O
modulates	O
translation	O
of	O
the	O
mRNA	other-biologything
and	O
impacts	O
the	O
activity	O
of	O
the	O
Twin	other-biologything
Arginine	other-biologything
Translocation	other-biologything
(	O
Tat	other-biologything
)	O
protein	O
secretion	O
apparatus	O
.	O

This	O
domain	O
is	O
the	O
target	O
of	O
the	O
anti	O
influenza	O
drugs	O
,	O
amantadine	O
and	O
its	O
ethyl	O
derivative	O
rimantadine	O
,	O
and	O
probably	O
also	O
the	O
methyl	O
derivative	O
of	O
rimantadine	other-biologything
,	O
adapromine	other-biologything
.	O

FtsZ	O
's	O
role	O
in	O
cell	O
division	O
is	O
analogous	O
to	O
that	O
of	O
tubulin	O
in	O
eukaryotic	O
cell	O
division	O
,	O
but	O
,	O
unlike	O
the	O
actin-myosin	O
ring	O
in	O
eukaryotes	O
,	O
FtsZ	other-biologything
has	O
no	O
known	O
motor	O
protein	O
associated	O
with	O
it	O
.	O

Due	O
to	O
the	O
COVID–19	other-biologything
pandemic	O
,	O
Major	O
League	O
Baseball	O
announced	O
the	O
cancellation	O
of	O
the	O
entire	O
Minor	O
League	O
Baseball	O
season	O
on	O
June	O
30	O
.	O

Molecular	O
analysis	O
of	O
the	O
``	O
hsp83	other-biologything
``	O
mutant	O
showed	O
that	O
HSP90	other-biologything
is	O
required	O
for	O
piRNA	other-biologything
biogenesis	O
,	O
a	O
set	O
of	O
small	O
RNAs	other-biologything
repressing	O
transposons	O
in	O
the	O
germline	O
.	O

It	O
is	O
composed	O
of	O
a	O
single	O
origin	O
recognition	O
complex	O
(	O
ORC	other-biologything
)	O
protein	O
,	O
Cdc6	other-biologything
/	O
ORC1	other-biologything
,	O
and	O
a	O
homohexamer	O
of	O
the	O
minichromosome	O
maintenance	O
(	O
MCM	other-biologything
)	O
protein	O
.	O

In	O
a	O
negative	O
feedback	O
loop	O
,	O
MDM2	other-biologything
itself	O
is	O
induced	O
by	O
the	O
p53	O
protein	O
.	O

The	O
p53	other-biologything
protein	O
is	O
continually	O
produced	O
and	O
degraded	O
in	O
cells	O
of	O
healthy	O
people	O
,	O
resulting	O
in	O
damped	O
oscillation	O
.	O

She	O
was	O
an	O
expert	O
in	O
HIV	other-biologything
drug	O
resistance	O
and	O
in	O
optimising	O
antiretroviral	O
therapy	O
.	O

The	O
ORC	other-biologything
,	O
Cdc6	other-biologything
,	O
and	O
Cdt1	other-biologything
together	O
are	O
required	O
for	O
the	O
stable	O
association	O
of	O
the	O
Mcm2-7	other-biologything
complex	O
with	O
replicative	O
origins	O
during	O
G1	other-biologything
phase	other-biologything
of	O
the	O
cell	O
cycle	O
.	O

As	O
the	O
wound	O
heals	O
,	O
the	O
clot	O
is	O
slowly	O
degraded	O
by	O
the	O
enzyme	O
plasmin	other-biologything
.	O

It	O
binds	O
various	O
microorganisms	O
by	O
recognizing	O
high-mannose-containing	other-biologything
glycoproteins	other-biologything
on	O
their	O
envelopes	O
and	O
especially	O
functions	O
as	O
receptor	O
for	O
several	O
viruses	O
such	O
as	O
HIV	other-biologything
and	O
Hepatitis	other-biologything
C	other-biologything
.	O
Binding	O
to	O
DC-SIGN	other-biologything
can	O
promote	O
HIV	other-biologything
and	O
Hepatitis	other-biologything
C	other-biologything
virus	O
to	O
infect	O
T-cell	other-biologything
from	O
dendritic	other-biologything
cells	other-biologything
.	O

Botulinum	other-biologything
toxin	other-biologything
has	O
been	O
found	O
to	O
be	O
useful	O
in	O
those	O
with	O
chronic	O
migraine	O
but	O
not	O
those	O
with	O
episodic	O
ones	O
.	O

The	O
other	O
family	O
of	O
CKIs	other-biologything
,	O
CIP/KIP	other-biologything
proteins	O
are	O
capable	O
of	O
inhibiting	O
all	O
CDKs	other-biologything
.	O

The	O
fatty	other-biologything
acids	other-biologything
are	O
absorbed	O
by	O
the	O
adipocytes	other-biologything
,	O
but	O
the	O
glycerol	other-biologything
and	O
chylomicron	other-biologything
remnants	O
remain	O
in	O
the	O
blood	other-biologything
plasma	other-biologything
,	O
ultimately	O
to	O
be	O
removed	O
from	O
the	O
circulation	O
by	O
the	O
liver	O
.	O

However	O
,	O
a	O
more	O
recent	O
study	O
assessing	O
neuroendocrine	O
effects	O
of	O
the	O
drug	O
in	O
normal	O
volunteers	O
and	O
subjects	O
with	O
a	O
history	O
of	O
cocaine	O
dependence	O
reported	O
observations	O
consistent	O
with	O
modest	O
MOR	other-biologything
antagonism	O
at	O
the	O
10	O
mg	O
dose	O
.	O

As	O
a	O
result	O
of	O
removing	O
this	O
complex	O
,	O
several	O
unwanted	O
DNA	other-biologything
damage	O
response	O
pathways	O
are	O
activated	O
,	O
including	O
ATM	other-biologything
kinase	other-biologything
signaling	other-biologything
,	O
ATR	other-biologything
kinase	other-biologything
signaling	other-biologything
,	O
non-homologous	other-biologything
end-joining	other-biologything
(	O
NHEJ	other-biologything
)	O
,	O
alt-NHEJ	other-biologything
,	O
C-NHEJ	other-biologything
,	O
5	other-biologything
'	other-biologything
resection	other-biologything
,	O
and	O
homology	other-biologything
directed	other-biologything
repair	other-biologything
(	O
HDR	other-biologything
)	O
.	O

HMGB1	other-biologything
can	O
also	O
induce	O
dendritic	O
cell	O
maturation	O
via	O
upregulation	O
of	O
CD80	other-biologything
,	O
CD83	other-biologything
,	O
CD86	other-biologything
and	O
CD11c	other-biologything
,	O
and	O
the	O
production	O
of	O
other	O
pro-inflammatory	O
cytokines	O
in	O
myeloid	O
cells	O
(	O
IL-1	other-biologything
,	O
TNF-a	other-biologything
,	O
IL-6	other-biologything
,	O
IL-8	other-biologything
)	O
,	O
and	O
it	O
can	O
lead	O
to	O
increased	O
expression	O
of	O
cell	O
adhesion	O
molecules	O
(	O
ICAM-1	other-biologything
,	O
VCAM-1	other-biologything
)	O
on	O
endothelial	O
cells	O
.	O

MAPK	other-biologything
can	O
regulate	O
transcription	O
factors	O
directly	O
or	O
indirectly	O
.	O

Upon	O
binding	O
of	O
a	O
Hh	O
protein	O
or	O
a	O
mutation	O
in	O
the	O
SSD	other-biologything
of	O
PTCH	other-biologything
,	O
the	O
pump	O
is	O
turned	O
off	O
allowing	O
oxysterols	O
to	O
accumulate	O
around	O
SMO	other-biologything
.	O

Methionine	other-biologything
aminopeptidase	other-biologything
2	other-biologything
,	O
a	O
member	O
of	O
the	O
dimetallohydrolase	other-biologything
family	O
,	O
is	O
a	O
cytosolic	O
metalloenzyme	other-biologything
that	O
catalyzes	O
the	O
hydrolytic	O
removal	O
of	O
N-terminal	O
methionine	other-biologything
residues	O
from	O
nascent	O
proteins	other-biologything
.	O

IFN-γ	O
secreted	O
by	O
CD4	other-biologything
T	other-biologything
cells	O
can	O
activate	O
macrophages	O
to	O
phagocytose	O
and	O
digest	O
intracellular	O
bacteria	O
and	O
protozoa	O
.	O

Transforming	O
growth	O
factor-β	other-biologything
(	O
TGF-β	other-biologything
)	O
principally	O
relays	O
its	O
effects	O
through	O
the	O
Smad	other-biologything
pathway	other-biologything
however	O
,	O
accumulating	O
evidence	O
indicate	O
that	O
alternative	O
signaling	O
routes	O
are	O
also	O
employed	O
by	O
this	O
pleiotropic	O
cytokine	O
.	O

Therefore	O
,	O
sonic	other-biologything
hedgehog	other-biologything
—	O
identified	O
as	O
an	O
important	O
regulator	O
of	O
Rb	O
—	O
may	O
also	O
prove	O
to	O
be	O
an	O
important	O
feature	O
in	O
regrowing	O
hair	O
cells	O
after	O
damage	O
.	O

It	O
is	O
characterized	O
by	O
progressive	O
loss	O
of	O
function	O
,	O
changes	O
in	O
transcriptional	O
profiles	O
and	O
sustained	O
expression	O
of	O
inhibitory	other-biologything
receptors	other-biologything
.	O

The	O
heparin	other-biologything
binding	O
site	O
of	O
protein	other-biologything
C	other-biologything
inhibitor	other-biologything
is	O
from	O
264-283	O
region	O
.	O

In	O
the	O
second	O
process	O
,	O
triggered	O
primarily	O
by	O
UVB	other-biologything
,	O
there	O
is	O
an	O
increase	O
in	O
production	O
of	O
melanin	other-biologything
(	O
melanogenesis	other-biologything
)	O
,	O
which	O
is	O
the	O
body	O
's	O
reaction	O
to	O
direct	O
DNA	other-biologything
photodamage	O
(	O
formation	O
of	O
pyrimidine	other-biologything
dimers	other-biologything
)	O
from	O
UV	other-biologything
radiation	other-biologything
.	O

Some	O
400	O
genes	other-biologything
are	O
shown	O
to	O
be	O
brain-specific	O
.	O

Lysyl-tRNA	other-biologything
synthetase	other-biologything
is	O
a	O
homodimer	O
localized	O
to	O
the	O
cytoplasm	O
which	O
belongs	O
to	O
the	O
class	O
II	O
family	O
of	O
tRNA	other-biologything
synthetases	other-biologything
.	O

p53	O
can	O
induce	O
transcription	O
of	O
MDM2	other-biologything
,	O
generating	O
a	O
negative	O
feedback	O
loop	O
.	O

Supplementation	O
of	O
protease	other-biologything
enzyme	other-biologything
has	O
been	O
shown	O
to	O
help	O
casein	other-biologything
intolerant	O
individuals	O
digest	O
the	O
protein	other-biologything
with	O
minimal	O
adverse	O
reaction	O
.	O

Despite	O
glucagon	other-biologything
's	O
lipolytic	O
activity	O
(	O
which	O
stimulates	O
PKA	other-biologything
as	O
well	O
)	O
in	O
vitro	O
,	O
the	O
role	O
of	O
glucagon	other-biologything
in	O
lipolysis	other-biologything
in	O
vivo	O
is	O
disputed	O
.	O

Retinol	other-biologything
is	O
called	O
vitamin	other-biologything
A	other-biologything
alcohol	O
or	O
,	O
more	O
often	O
,	O
simply	O
vitamin	other-biologything
A	other-biologything
.	O
Retinal	other-biologything
can	O
also	O
be	O
oxidized	O
to	O
retinoic	other-biologything
acid	other-biologything
(	O
RA	other-biologything
)	O
:	O

antibiotic	other-biologything
resistance	O
,	O
beta	other-biologything
lactamase	other-biologything
,	O
beta	other-biologything
galactosidase	other-biologything
.	O

T	other-biologything
cell	other-biologything
exhaustion	O
is	O
a	O
state	O
of	O
dysfunctional	O
T	other-biologything
cells	other-biologything
.	O

Protease	other-biologything
inactivation	O
results	O
as	O
a	O
consequence	O
of	O
trapping	O
the	O
protease	other-biologything
in	O
an	O
equimolar	O
complex	O
with	O
antithrombin	other-biologything
in	O
which	O
the	O
active	O
site	O
of	O
the	O
protease	other-biologything
enzyme	other-biologything
is	O
inaccessible	O
to	O
its	O
usual	O
substrate	O
.	O

Modulation	O
of	O
cellular	O
TTRAP	other-biologything
level	O
affects	O
cell	O
viability	O
in	O
the	O
presence	O
of	O
TGF-β	other-biologything
,	O
suggesting	O
that	O
the	O
protein	O
is	O
an	O
important	O
component	O
of	O
the	O
TGF-β	other-biologything
induced	O
apoptotic	O
process	O
.	O

Several	O
rod	O
shaped	O
species	O
,	O
including	O
``	O
Escherichia	other-biologything
coli	other-biologything
``	O
and	O
``	O
Caulobacter	other-biologything
crescentus	other-biologything
``	O
,	O
use	O
one	O
or	O
more	O
inhibitors	O
of	O
FtsZ	other-biologything
assembly	O
that	O
form	O
a	O
bipolar	O
gradient	O
in	O
the	O
cell	O
,	O
enhancing	O
polymerization	O
of	O
FtsZ	other-biologything
at	O
the	O
cell	O
center	O
.	O

In	O
a	O
patient	O
with	O
infrequent	O
menstruation	O
,	O
an	O
FSH	other-biologything
level	O
and	O
estrogen	O
level	O
could	O
be	O
measured	O
at	O
random	O
and	O
is	O
valid	O
if	O
the	O
estrogen	other-biologything
level	other-biologything
is	O
low	O
.	O

Leptomycin	other-biologything
B	other-biologything
also	O
inhibits	O
the	O
export	O
and	O
translation	O
of	O
many	O
RNAs	other-biologything
,	O
including	O
COX-2	other-biologything
and	O
c-Fos	other-biologything
mRNAs	other-biologything
,	O
by	O
inhibiting	O
export	O
of	O
ribonucleoproteins	O
.	O

The	O
distribution	O
of	O
the	O
arthropathy	O
is	O
distinctive	O
,	O
but	O
not	O
unique	O
,	O
frequently	O
affecting	O
the	O
second	O
and	O
third	O
metacarpophalangeal	other-biologything
joints	other-biologything
of	O
the	O
hand	O
.	O

This	O
enzyme	O
belongs	O
to	O
the	O
family	O
of	O
oxidoreductases	O
,	O
to	O
be	O
specific	O
,	O
those	O
acting	O
on	O
the	O
aldehyde	O
or	O
oxo	O
group	O
of	O
donor	O
with	O
NAD+	other-biologything
or	O
NADP+	other-biologything
as	O
acceptor	O
.	O

In	O
experiments	O
,	O
this	O
altered	O
form	O
significantly	O
outperformed	O
natural	O
IL-2	other-biologything
in	O
impeding	O
tumor	O
growth	O
.	O

Calmodulin	other-biologything
,	O
when	O
activated	O
by	O
calcium	O
may	O
bind	O
weakly	O
to	O
the	O
CH	other-biologything
domain	O
and	O
inhibit	O
calponin	other-biologything
binding	O
with	O
α-actin	other-biologything
.	O

Using	O
Kyte-Doolittle	other-biologything
analysis	other-biologything
,	O
the	O
amino	O
acid	O
sequence	O
of	O
CD36	other-biologything
predicts	O
a	O
hydrophobic	O
region	O
near	O
each	O
end	O
of	O
the	O
protein	O
large	O
enough	O
to	O
span	O
cellular	O
membranes	O
.	O

The	O
released	O
E2F	other-biologything
is	O
then	O
free	O
to	O
act	O
as	O
a	O
transcription	O
factor	O
and	O
it	O
subsequently	O
binds	O
to	O
DNA	other-biologything
promoter	O
regions	O
and	O
activates	O
the	O
expression	O
of	O
proteins	O
required	O
in	O
the	O
next	O
stages	O
of	O
the	O
cell	O
cycle	O
and	O
in	O
DNA	other-biologything
replication	O
.	O

DNA	other-biologything
damage	O
can	O
induce	O
apoptosis	O
when	O
the	O
ATM	other-biologything
kinase	other-biologything
and	O
Chk2	other-biologything
phosphorylate	O
p53	other-biologything
on	O
its	O
Ser-15	other-biologything
and	O
Ser-20	other-biologything
residues	O
which	O
activates	O
p53	other-biologything
and	O
stabilizes	O
it	O
by	O
allowing	O
it	O
to	O
dissociate	O
from	O
the	O
E3	other-biologything
ubiquitin	other-biologything
protein	other-biologything
ligase	O
MDM2	other-biologything
.	O

Guanine	other-biologything
nucleotide-binding	other-biologything
protein	other-biologything
G	O
(	O
I	O
)	O
/G	O
(	O
S	O
)	O
/G	O
(	O
T	O
)	O
subunit	O
beta-2	other-biologything
is	O
a	O
protein	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
GNB2	other-biologything
``	O
gene	O
.	O

The	O
disease	O
is	O
caused	O
by	O
a	O
mutation	O
in	O
the	O
Huntingtin	other-biologything
gene	other-biologything
,	O
on	O
chromosome	other-biologything
4	other-biologything
,	O
which	O
causes	O
abnormally	O
large	O
numbers	O
of	O
glutamate	other-biologything
residues	O
in	O
the	O
protein	other-biologything
.	O

Laminin	other-biologything
is	O
vital	O
for	O
the	O
maintenance	O
and	O
survival	O
of	O
tissues	O
.	O

HMGB1	other-biologything
is	O
a	O
major	O
mediator	O
of	O
endotoxin	O
shock	O
and	O
is	O
recognized	O
as	O
a	O
DAMP	other-biologything
by	O
certain	O
immune	O
cells	O
,	O
triggering	O
an	O
inflammatory	O
response	O
.	O

gp130	other-biologything
preferentially	O
activates	O
STAT3	other-biologything
which	O
it	O
can	O
do	O
through	O
four	O
STAT3	other-biologything
activation	O
consensus	O
sequences	O
YXXQ	O
:	O
(	O
YRHQ	O
)	O
,	O
(	O
YFKQ	O
)	O
,	O
Y905	O
(	O
YLPQ	O
)	O
,	O
Y915	O
(	O
YMPQ	O
)	O
.	O

The	O
responses	O
of	O
antibodies	O
to	O
these	O
proteins	O
are	O
used	O
to	O
classify	O
the	O
different	O
serotypes	O
of	O
influenza	O
A	other-biologything
viruses	other-biologything
,	O
hence	O
the	O
``	O
H	other-biologything
``	O
and	O
``	O
N	other-biologything
``	O
in	O
``	O
H5N1	other-biologything
``	O
.	O

This	O
data	O
is	O
historical	O
,	O
does	O
not	O
show	O
the	O
influence	O
of	O
important	O
additional	O
factors	O
such	O
as	O
estrogen	other-biologything
receptor	other-biologything
(	other-biologything
ER	other-biologything
)	other-biologything
or	O
HER2/neu	other-biologything
receptor	other-biologything
status	O
,	O
and	O
does	O
not	O
reflect	O
the	O
impact	O
of	O
newer	O
treatments	O
.	O

It	O
has	O
also	O
been	O
proposed	O
that	O
Bub1	other-biologything
binds	O
p53	other-biologything
to	O
prevent	O
it	O
from	O
activating	O
pro-apoptotic	O
genes	O
,	O
therefore	O
p53	other-biologything
is	O
able	O
to	O
induce	O
apoptosis	O
when	O
Bub1	other-biologything
is	O
depleted	O
.	O

Activation	O
of	O
pro-caspase	other-biologything
8	other-biologything
initiates	O
apoptosis	O
via	O
signaling	O
from	O
cell-surface	O
death	O
receptors	O
such	O
as	O
Fas	other-biologything
proteins	O
and	O
their	O
ligands	O
FADD	other-biologything
and	O
DAXX	other-biologything
.	O

During	O
the	O
G1	other-biologything
phase	O
,	O
it	O
is	O
synthesized	O
rapidly	O
and	O
accumulates	O
in	O
the	O
nucleus	O
,	O
and	O
is	O
degraded	O
as	O
the	O
cell	O
enters	O
the	O
S	other-biologything
phase	other-biologything
.	O

``	O
Kcne2	other-biologything
``	O
-/-	O
mice	O
exhibit	O
increased	O
seizure	O
susceptibility	O
,	O
reduced	O
immobility	O
time	O
in	O
the	O
tail	O
suspension	O
test	O
,	O
and	O
reduced	O
cerebrospinal	O
fluid	O
``	O
myo	O
''	O
-inositol	O
content	O
,	O
compared	O
to	O
wild-type	O
littermates	O
.	O

The	O
MAP	other-biologything
kinase	other-biologything
ERK	other-biologything
activates	O
the	O
downstream	O
transcription	O
factors	O
Myc	other-biologything
,	O
AP-1	other-biologything
and	O
Fos	other-biologything
which	O
in	O
turn	O
activate	O
the	O
transcription	O
of	O
the	O
Cdk4	other-biologything
,	O
Cdk6	other-biologything
and	O
cyclin	other-biologything
D	other-biologything
genes	O
,	O
and	O
increase	O
ribosome	O
biogenesis	O
.	O

Clathrin-associated	other-biologything
protein	other-biologything
complexes	other-biologything
are	O
believed	O
to	O
interact	O
with	O
the	O
cytoplasmic	O
tails	O
of	O
membrane	other-biologything
proteins	other-biologything
,	O
leading	O
to	O
their	O
selection	O
and	O
concentration	O
.	O

There	O
are	O
several	O
known	O
mechanisms	O
for	O
regulation	O
of	O
Mdm2	other-biologything
.	O

Lectin	other-biologything
and	O
antibody	other-biologything
arrays	other-biologything
provide	O
high-throughput	O
screening	O
of	O
many	O
samples	O
containing	O
glycans	O
.	O

When	O
a	O
mutation	O
occurs	O
in	O
protein	O
p16	O
,	O
it	O
prevents	O
the	O
protein	O
kinase	O
of	O
CDK4	other-biologything
,	O
which	O
results	O
in	O
the	O
inactivation	O
of	O
the	O
tumor	O
suppressor	O
gene	O
.	O

While	O
the	O
function	O
of	O
TMEM128	other-biologything
is	O
poorly	O
understood	O
,	O
it	O
interacts	O
with	O
several	O
proteins	O
associated	O
with	O
the	O
cell	O
cycle	O
,	O
signal	O
transduction	O
,	O
and	O
memory	O
.	O

The	O
guanidine	other-biologything
group	other-biologything
of	other-biologything
arginine	other-biologything
residues	O
condense	O
with	O
malondialdehyde	other-biologything
to	O
give	O
2-aminopyrimidines	other-biologything
.	O

It	O
has	O
influenced	O
mutations	O
in	O
``	O
HBB	other-biologything
``	O
in	O
various	O
degrees	O
resulting	O
in	O
the	O
existence	O
of	O
numerous	O
HBB	other-biologything
variants	O
.	O

Multisynthetase	O
complex	O
auxiliary	O
component	O
p38	other-biologything
has	O
been	O
shown	O
to	O
interact	O
with	O
Parkin	other-biologything
(	O
ligase	O
)	O
,	O
P53	other-biologything
and	O
KARS	other-biologything
.	O

Immunoprecipitation	O
studies	O
with	O
protein	other-biologything
A	other-biologything
conjugated	O
to	O
beads	O
are	O
also	O
commonly	O
used	O
to	O
purify	O
proteins	O
or	O
protein	O
complexes	O
indirectly	O
through	O
antibodies	O
against	O
the	O
protein	O
or	O
protein	O
complex	O
of	O
interest	O
.	O

Fibronectin	O
domains	O
of	O
L1	other-biologything
protein	other-biologything
are	O
also	O
capable	O
of	O
binding	O
cell	O
surface	O
integrins	O
.	O

Glucose	other-biologything
6-phosphate	other-biologything
is	O
converted	O
to	O
fructose	other-biologything
6-phosphate	other-biologything
(	O
F6P	other-biologything
)	O
and	O
glyceraldehyde	other-biologything
3-phosphate	other-biologything
(	O
G3P	other-biologything
)	O
during	O
glycolysis	O
.	O

CTP	other-biologything
is	O
subsequently	O
formed	O
by	O
the	O
amination	O
of	O
UTP	other-biologything
by	O
the	O
catalytic	O
activity	O
of	O
CTP	other-biologything
synthetase	other-biologything
.	O

Presumably	O
,	O
this	O
increased	O
affinity	O
and	O
concentration	O
of	O
p53	other-biologything
turns	O
the	O
p53-E1B-55k	other-biologything
complex	other-biologything
into	O
a	O
powerful	O
repressor	O
.	O

Studies	O
show	O
that	O
for	O
comets	other-biologything
with	O
high	O
orbital	O
inclinations	O
and	O
perihelion	O
distances	O
of	O
less	O
than	O
about	O
2	O
astronomical	O
units	O
,	O
the	O
cumulative	O
effect	O
of	O
gravitational	O
perturbations	O
over	O
many	O
orbits	O
is	O
adequate	O
to	O
reduce	O
the	O
perihelion	O
distance	O
to	O
very	O
small	O
values	O
.	O

FcRn	other-biologything
extends	O
the	O
half-life	O
of	O
IgG	other-biologything
and	O
serum	O
albumin	O
by	O
reducing	O
lysosomal	other-biologything
degradation	O
in	O
endothelial	other-biologything
cells	other-biologything
and	O
bone-marrow	other-biologything
derived	other-biologything
cells	other-biologything
.	O

It	O
is	O
also	O
used	O
to	O
visualise	O
DNA	other-biologything
in	O
gel	O
electrophoresis	O
.	O

For	O
example	O
,	O
NeuN	other-biologything
/	O
Fox3	other-biologything
and	O
GFAP	other-biologything
are	O
antigens	O
commonly	O
used	O
to	O
detect	O
neurons	O
,	O
glia	O
,	O
and	O
ependymal	O
cells	O
.	O

Many	O
factors	O
can	O
be	O
bound	O
to	O
fibrin	other-biologything
scaffold	O
and	O
those	O
can	O
be	O
released	O
in	O
a	O
cell-controlled	O
manner	O
.	O

Mouse	other-biologything
double	other-biologything
minute	other-biologything
2	other-biologything
homolog	other-biologything
(	O
MDM2	other-biologything
)	O
also	O
known	O
as	O
E3	other-biologything
ubiquitin-protein	other-biologything
ligase	other-biologything
Mdm2	other-biologything
is	O
a	O
protein	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
MDM2	other-biologything
``	O
gene	O
.	O

This	O
degrades	O
threonine	other-biologything
before	O
the	O
herbivore	O
can	O
absorb	O
it	O
,	O
starving	O
the	O
herbivore	O
of	O
an	O
essential	O
amino	other-biologything
acid	other-biologything
.	O

It	O
also	O
interacts	O
with	O
nucleosomes	O
to	O
loosen	O
packed	O
DNA	other-biologything
and	O
remodel	O
the	O
chromatin	other-biologything
.	O

``	O
&	O
gt	O
;	O
&	O
lt	O
;	O
/ref	O
&	O
gt	O
;	O
Both	O
formation	O
of	O
the	O
primitive	O
streak	O
and	O
mesenchymal	other-biologything
tissue	other-biologything
is	O
dependent	O
on	O
the	O
Wnt/β-catenin	other-biologything
pathway	O
.	O

Based	O
on	O
mitochondrial	O
DNA	other-biologything
,	O
specifically	O
the	O
regions	O
that	O
encode	O
cytochrome	O
c	O
oxidase	O
and	O
cytochrome	O
b	O
,	O
Savi	other-biologything
's	O
pipistrelle	O
is	O
most	O
closely	O
related	O
to	O
``	O
Hypsugo	other-biologything
alaschanicus	other-biologything
``	O
.	O

Mutation	O
in	O
any	O
one	O
of	O
four	O
residues	O
in	O
KPNA	other-biologything
at	O
positions	O
434	O
,	O
474	O
,	O
477	O
or	O
484	O
prevent	O
binding	O
to	O
STAT1	other-biologything
.	O

Whereas	O
RAF	other-biologything
and	O
MAPK	other-biologything
are	O
both	O
serine/threonine	O
kinases	O
,	O
MAPKK	other-biologything
is	O
a	O
tyrosine/threonine	other-biologything
kinase	other-biologything
.	O

In	O
these	O
cells	O
,	O
KCNQ1-KCNE2	other-biologything
K+	other-biologything
channels	O
,	O
which	O
are	O
constitutively	O
active	O
,	O
provide	O
a	O
conduit	O
to	O
return	O
K+	other-biologything
ions	O
back	O
to	O
the	O
stomach	O
lumen	O
.	O

Moreover	O
,	O
the	O
mutant	O
p53	other-biologything
protein	O
itself	O
can	O
inhibit	O
normal	O
p53	other-biologything
protein	O
levels	O
.	O

Other	O
names	O
in	O
common	O
use	O
include	O
dextrin	O
6-glucosyltransferase	other-biologything
,	O
and	O
dextran	other-biologything
dextrinase	other-biologything
.	O

Podoptosis	other-biologything
is	O
caspase-independent	O
and	O
,	O
therefore	O
,	O
different	O
from	O
apoptosis	other-biologything
.	O

Chondrostoma	other-biologything
orientale	other-biologything
is	O
a	O
species	O
of	O
ray-finned	O
fish	O
in	O
the	O
genus	O
``	O
Chondrostoma	other-biologything
``	O
which	O
is	O
endemic	O
to	O
Iran	O
.	O

This	O
protein	O
is	O
involved	O
in	O
the	O
misfolding	O
of	O
normal	O
prion	other-biologything
proteins	other-biologything
in	O
the	O
cell	O
membrane	O
to	O
the	O
infectious	O
prion	O
form	O
.	O

Although	O
many	O
of	O
the	O
afore-mentioned	O
inhibitors	O
share	O
the	O
same	O
Hsp90	other-biologything
binding	O
site	O
(	O
either	O
N-	O
or	O
C-terminal	O
)	O
,	O
it	O
has	O
been	O
shown	O
that	O
some	O
of	O
these	O
drugs	O
preferentially	O
access	O
distinct	O
Hsp90	other-biologything
populations	O
,	O
which	O
are	O
differentiated	O
by	O
the	O
extent	O
of	O
their	O
post-translational	O
modification	O
.	O

Glycine	other-biologything
is	O
also	O
an	O
inhibitory	O
neurotransmitter	O
-	O
interference	O
with	O
its	O
release	O
within	O
the	O
spinal	O
cord	O
(	O
such	O
as	O
during	O
a	O
``	O
Clostridium	O
tetani	O
''	O
infection	O
)	O
can	O
cause	O
spastic	O
paralysis	O
due	O
to	O
uninhibited	O
muscle	O
contraction	O
.	O

For	O
instance	O
,	O
necroptotic	O
cells	O
release	O
highly	O
immunogenic	O
DAMPs	other-biologything
,	O
initiating	O
adaptive	O
immunity	O
.	O

Urease	other-biologything
Inhibition	O
specifically	O
prevents	O
the	O
following	O
reaction	O
:	O

The	O
C-terminus	O
of	O
the	O
NLRs	other-biologything
consists	O
of	O
a	O
leucine-rich	O
repeat	O
(	O
LRR	other-biologything
)	O
motif	O
,	O
which	O
is	O
involved	O
in	O
sensing	O
the	O
pathogen	O
virulence	O
factors	O
.	O

The	O
protein	O
encoded	O
by	O
this	O
gene	O
is	O
a	O
dual	O
specificity	O
protein	O
kinase	O
that	O
belongs	O
to	O
the	O
MAP	other-biologything
kinase	other-biologything
kinase	O
family	O
.	O

When	O
bound	O
to	O
ADP	other-biologything
,	O
conformational	O
changes	O
occur	O
within	O
the	O
aggregin	other-biologything
molecule	O
and	O
consequently	O
,	O
it	O
dissociates	O
from	O
the	O
two	O
subunits	O
.	O

Many	O
proteins	O
interact	O
with	O
PCNA	other-biologything
via	O
the	O
two	O
known	O
PCNA	other-biologything
-interacting	O
motifs	O
PCNA-interacting	other-biologything
peptide	other-biologything
(	O
PIP	other-biologything
)	O
box	O
and	O
AlkB	other-biologything
homologue	other-biologything
2	other-biologything
PCNA	other-biologything
interacting	other-biologything
motif	other-biologything
(	O
APIM	other-biologything
)	O
.	O

Furthermore	O
,	O
when	O
incubated	O
in	O
vitro	O
with	O
either	O
mitogens	O
or	O
specific	O
antigens	O
,	O
they	O
produce	O
specific	O
antibodies	O
against	O
diphtheria	other-biologything
toxoid	other-biologything
,	other-biologything
poliovirus	other-biologything
,	O
Streptococcus	other-biologything
pneumoniae	other-biologything
,	O
Haemophilus	other-biologything
influenzae	other-biologything
,	O
Staphylococcus	other-biologything
aureus	other-biologything
,	O
and	O
the	O
lipopolysaccharide	other-biologything
of	O
``	O
E.	O
coli	O
''	O
.	O

When	O
milk	O
analogues	O
lack	O
the	O
vitamins	O
or	O
dietary	O
minerals	O
present	O
in	O
dairy	O
milk	O
(	O
such	O
as	O
vitamin	O
B12	other-biologything
or	O
calcium	O
)	O
,	O
they	O
may	O
be	O
fortified	O
.	O

Amyloid	other-biologything
beta	other-biologything
is	O
commonly	O
thought	O
to	O
be	O
intrinsically	O
unstructured	O
,	O
meaning	O
that	O
in	O
solution	O
it	O
does	O
not	O
acquire	O
a	O
unique	O
tertiary	O
fold	O
but	O
rather	O
populates	O
a	O
set	O
of	O
structures	O
.	O

This	O
enzyme	O
participates	O
in	O
benzoate	O
degradation	O
via	O
CoA	other-biologything
ligation	O
.	O

Draba	other-biologything
pterosperma	other-biologything
is	O
an	O
uncommon	O
species	O
of	O
flowering	O
plant	O
in	O
the	O
family	O
Brassicaceae	other-biologything
known	O
by	O
the	O
common	O
name	O
wingedseed	O
draba	O
.	O

TP63	other-biologything
can	O
also	O
regulate	O
PERP	other-biologything
expression	O
with	O
TP53	other-biologything
in	O
human	O
cancer	O
.	O

IL-2	other-biologything
binds	O
to	O
these	O
pulmonary	other-biologything
cells	other-biologything
differently	O
than	O
it	O
does	O
to	O
T	other-biologything
cells	other-biologything
,	O
so	O
IL-2	other-biologything
research	O
involves	O
understanding	O
the	O
differences	O
between	O
these	O
binding	O
mechanisms	O
.	O

Mediator	O
of	O
RNA	other-biologything
polymerase	other-biologything
II	other-biologything
transcription	O
subunit	O
7	O
is	O
an	O
enzyme	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
MED7	other-biologything
``	O
gene	O
.	O

Known	O
targets	O
of	O
these	O
methyltransferases	other-biologything
in	O
humans	O
include	O
RCC-1	other-biologything
(	O
a	O
regulator	O
of	O
nuclear	O
transport	O
proteins	O
)	O
and	O
Retinoblastoma	other-biologything
protein	other-biologything
(	O
a	O
tumor	O
suppressor	O
protein	O
that	O
inhibits	O
excessive	O
cell	O
division	O
)	O
.	O

Two	O
RNA	other-biologything
species	O
with	O
tightly	O
regulated	O
secondary	O
structures	O
are	O
ribosomal	O
RNA	other-biologything
(	O
rRNA	other-biologything
)	O
and	O
transfer	O
RNA	other-biologything
(	O
tRNA	other-biologything
)	O
which	O
are	O
essential	O
in	O
translation	O
of	O
mRNA	other-biologything
to	O
protein	O
.	O

``	O
Siderastrea	other-biologything
siderea	other-biologything
``	O
is	O
a	O
very	O
slow	O
growing	O
species	O
that	O
lives	O
to	O
a	O
great	O
age	O
.	O

Specific	O
STATs	other-biologything
appear	O
to	O
bind	O
to	O
specific	O
importin	O
proteins	O
.	O

This	O
gene	O
encodes	O
the	O
alpha	other-biologything
1	other-biologything
adaptin	other-biologything
subunit	other-biologything
of	O
the	O
adaptor	other-biologything
protein	other-biologything
2	other-biologything
(	O
AP2	other-biologything
adaptors	other-biologything
)	O
complex	O
found	O
in	O
clathrin	other-biologything
coated	other-biologything
vesicles	other-biologything
.	O

Oligohydramnios	other-biologything
is	O
the	O
decrease	O
in	O
amniotic	O
fluid	O
volume	O
sufficient	O
to	O
cause	O
deformations	O
in	O
morphogenesis	O
of	O
the	O
baby	O
.	O

Their	O
function	O
,	O
inhibiting	O
CDK4/6	other-biologything
,	O
is	O
to	O
block	O
progression	O
of	O
the	O
cell	O
cycle	O
beyond	O
the	O
G1	other-biologything
restriction	O
point	O
.	O

Tat	other-biologything
protein	other-biologything
also	O
associates	O
with	O
RNA	other-biologything
polymerase	other-biologything
II	other-biologything
complexes	O
during	O
early	O
transcription	O
elongation	O
after	O
the	O
promoter	O
clearance	O
and	O
before	O
the	O
synthesis	O
of	O
full-length	O
TAR	other-biologything
RNA	other-biologything
transcript	O
.	O

The	O
molecular	O
weight	O
of	O
TMEM176B	other-biologything
is	O
29.1	O
kiloDaltons	O
(	O
kdal	O
)	O
.	O

When	O
tested	O
from	O
whole	O
blood	O
,	O
monocytes	O
do	O
not	O
respond	O
to	O
BCG	other-biologything
and	O
IFNg	other-biologything
doses	O
with	O
IL-12	other-biologything
production	O
.	O

:	O
H4K20	other-biologything
)	O
mono	O
,	O
di	O
and	O
tri-methylation	O
appear	O
to	O
have	O
different	O
meanings	O
.	O

GOT2	other-biologything
has	O
been	O
seen	O
to	O
have	O
a	O
role	O
in	O
cell	O
proliferation	O
,	O
especially	O
in	O
terms	O
of	O
tumor	O
growth	O
.	O

Coronaviruses	other-biologything
bind	O
to	O
macrophages	other-biologything
via	O
the	O
Dendritic	other-biologything
Cell-Specific	other-biologything
Intercellular	other-biologything
adhesion	other-biologything
molecule-3-Grabbing	other-biologything
Non-integrin	other-biologything
(	O
DC-SIGN	other-biologything
)	O
which	O
is	O
a	O
trans-membrane	other-biologything
protein	other-biologything
encoded	O
in	O
humans	O
by	O
the	O
``	O
CD209	other-biologything
``	O
gene	O
.	O

Abemaciclib	other-biologything
achieved	O
therapeutic	O
concentrations	O
in	O
brain	O
metastases	O
tissue	O
,	O
far	O
exceeding	O
those	O
necessary	O
for	O
CDK4	other-biologything
and	O
CDK6	other-biologything
inhibition	O
.	O

However	O
,	O
in	O
order	O
to	O
cause	O
true	O
melanogenesis	other-biologything
-tanning	O
by	O
means	O
of	O
UV	other-biologything
exposure	O
,	O
some	O
direct	O
DNA	other-biologything
photodamage	O
must	O
first	O
be	O
produced	O
,	O
and	O
this	O
requires	O
UVB	other-biologything
exposure	O
(	O
as	O
present	O
in	O
natural	O
sunlight	O
,	O
or	O
sunlamps	O
that	O
produce	O
UVB	other-biologything
)	O
.	O

Cells	O
of	O
individuals	O
homozygous	O
for	O
the	O
CCR5	other-biologything
gene	O
variant	O
Δ32	other-biologything
(	O
CCR5Δ32/Δ32	other-biologything
)	O
lack	O
the	O
CCR5	other-biologything
cell-surface	O
expression	O
,	O
meaning	O
that	O
they	O
are	O
naturally	O
resistant	O
to	O
infection	O
with	O
CCR5	other-biologything
tropic	O
HIV	other-biologything
strains	O
(	O
R5	other-biologything
HIV	other-biologything
)	O
.	O

HBB	other-biologything
interacts	O
with	O
Hemoglobin	other-biologything
,	O
alpha	other-biologything
1	other-biologything
(	other-biologything
HBA1	other-biologything
)	other-biologything
to	O
form	O
haemoglobin	other-biologything
A	other-biologything
,	O
the	O
major	O
haemoglobin	other-biologything
in	O
adult	O
humans	O
.	O

The	O
precise	O
structure	O
of	O
the	O
prion	O
is	O
not	O
known	O
,	O
though	O
they	O
can	O
be	O
formed	O
spontaneously	O
by	O
combining	O
PrPC	other-biologything
,	O
homopolymeric	other-biologything
polyadenylic	other-biologything
acid	other-biologything
,	O
and	O
lipids	other-biologything
in	O
a	O
protein	other-biologything
misfolding	other-biologything
cyclic	other-biologything
amplification	other-biologything
(	O
PMCA	other-biologything
)	O
reaction	O
even	O
in	O
the	O
absence	O
of	O
pre-existing	O
infectious	O
prions	other-biologything
.	O

These	O
proteins	O
act	O
as	O
electron	O
shuttles	O
by	O
switching	O
the	O
oxidation	O
state	O
of	O
the	O
heme	other-biologything
iron	other-biologything
atom	other-biologything
between	O
ferrous	other-biologything
(	O
Fe2+	other-biologything
)	O
and	O
ferric	other-biologything
(	O
Fe3+	other-biologything
)	O
.	O

Pestell	O
subsequently	O
initiated	O
the	O
company	O
's	O
currently	O
active	O
cancer	O
treatment	O
clinical	O
trial	O
initiatives	O
targeting	O
CCR5	other-biologything
receiving	O
fast	O
track	O
designation	O
in	O
May	O
2019	O
.	O

Several	O
substances	O
are	O
known	O
to	O
increase	O
the	O
amount	O
of	O
direct	O
DNA	other-biologything
damage	O
(	O
thymine	O
dimers	O
)	O
.	O

These	O
motifs	O
contain	O
conserved	O
H-C	other-biologything
links	O
.	O

Laminin	other-biologything
G	other-biologything
-containing	O
proteins	O
appear	O
to	O
have	O
a	O
wide	O
variety	O
of	O
roles	O
in	O
cell	other-biologything
adhesion	other-biologything
,	O
signalling	O
,	O
migration	O
,	O
assembly	O
and	O
differentiation	O
.	O

Mitogen-activated	other-biologything
protein	other-biologything
kinase	other-biologything
scaffold	other-biologything
protein	other-biologything
1	other-biologything
is	O
a	O
scaffold	O
protein	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
MAPKSP1	other-biologything
``	O
gene	O
.	O

Thus	O
,	O
the	O
two	O
substrates	O
of	O
this	O
enzyme	O
are	O
S-adenosyl	other-biologything
methionine	other-biologything
and	O
cytochrome	other-biologything
c-arginine	other-biologything
,	O
whereas	O
its	O
two	O
products	O
are	O
S-adenosylhomocysteine	other-biologything
and	O
cytochrome	other-biologything
c-Nomega-methyl-arginin	other-biologything
e	O
.	O

Lone	other-biologything
star	other-biologything
ticks	other-biologything
are	O
native	O
to	O
the	O
regions	O
of	O
the	O
US	O
where	O
reactions	O
occurred	O
and	O
were	O
found	O
to	O
be	O
the	O
vector	O
.	O

Mitogen-activated	other-biologything
protein	other-biologything
kinase	other-biologything
kinase	other-biologything
kinase	other-biologything
kinase	other-biologything
2	other-biologything
is	O
an	O
enzyme	O
that	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
MAP4K2	other-biologything
``	O
gene	O
.	O

Specimens	O
of	O
nine	O
children	O
had	O
human	O
coronavirus	O
HKU1	other-biologything
.	O

Tryptophan	other-biologything
hydroxylase	other-biologything
1	other-biologything
(	O
TPH1	other-biologything
)	O
is	O
an	O
isoenzyme	O
of	O
tryptophan	O
hydroxylase	O
which	O
in	O
humans	O
is	O
encoded	O
by	O
the	O
``	O
TPH1	other-biologything
``	O
gene	O
.	O

One	O
of	O
the	O
most	O
common	O
types	O
of	O
shuttle	other-biologything
vectors	other-biologything
is	O
the	O
yeast	other-biologything
shuttle	other-biologything
vector	other-biologything
.	O

The	O
movement	O
of	O
SR	other-biologything
proteins	other-biologything
from	O
the	O
RNA	other-biologything
polymerase	other-biologything
II	other-biologything
to	O
the	O
new	O
RNA	other-biologything
strand	O
prevents	O
the	O
new	O
RNA	other-biologything
strand	O
,	O
which	O
is	O
complementary	O
to	O
the	O
template	O
DNA	other-biologything
strand	O
,	O
from	O
binding	O
to	O
the	O
template	O
DNA	other-biologything
strand	O
thus	O
preventing	O
R	O
loops	O
.	O

Sonic	other-biologything
hedgehog	other-biologything
(	O
SHH	other-biologything
)	O
are	O
morphogens	O
that	O
are	O
essential	O
to	O
early	O
patterning	O
in	O
the	O
developing	O
embryo	O
.	O

Because	O
different	O
cellular	O
mechanisms	O
require	O
distinct	O
levels	O
of	O
TGF-β	other-biologything
signaling	O
,	O
the	O
inactive	O
complex	O
of	O
this	O
cytokine	O
gives	O
opportunity	O
for	O
a	O
proper	O
mediation	O
of	O
TGF-β	other-biologything
signaling	O
.	O

c-Fos	other-biologything
is	O
also	O
a	O
target	O
of	O
miR-7b	other-biologything
in	O
mice	O
.	O

Recombinant	O
antithrombins	other-biologything
with	O
properties	O
similar	O
to	O
those	O
of	O
normal	O
human	O
antithrombin	other-biologything
have	O
been	O
produced	O
using	O
baculovirus-infected	O
insect	O
cells	O
and	O
mammalian	O
cell	O
lines	O
grown	O
in	O
cell	O
culture	O
.	O

It	O
was	O
also	O
thanks	O
to	O
his	O
leadership	O
that	O
President	O
Bill	O
Clinton	O
issued	O
an	O
apology	O
to	O
the	O
university	O
for	O
the	O
Tuskegee	O
syphilis	other-biologything
experiment	O
in	O
1997	O
.	O

Association	O
of	O
the	O
origin	other-biologything
recognition	other-biologything
complex	other-biologything
(	O
ORC	other-biologything
)	O
with	O
a	O
replication	O
origin	O
recruits	O
the	O
cell	other-biologything
division	other-biologything
cycle	other-biologything
6	other-biologything
protein	other-biologything
(	O
Cdc6	other-biologything
)	O
to	O
form	O
a	O
platform	O
for	O
the	O
loading	O
of	O
the	O
minichromosome	O
maintenance	O
(	O
Mcm	other-biologything
2-7	other-biologything
)	O
complex	O
proteins	O
,	O
facilitated	O
by	O
the	O
chromatin	O
licensing	O
and	O
DNA	other-biologything
replication	O
factor	O
1	O
protein	O
(	O
Cdt1	other-biologything
)	O
.	O

Low	O
levels	O
of	O
dopamine	other-biologything
lead	O
to	O
high	O
levels	O
of	O
prolactin	other-biologything
.	O

Glycine	other-biologything
is	O
integral	O
to	O
the	O
formation	O
of	O
alpha-helices	O
in	O
secondary	O
protein	O
structure	O
due	O
to	O
its	O
compact	O
form	O
.	O

USP18	other-biologything
inhibits	O
IFN-I	other-biologything
signaling	O
by	O
disrupting	O
the	O
receptor	O
complex	O
and	O
the	O
subsequent	O
JAK-STAT	other-biologything
signaling	O
pathway	O
.	O

Folic	other-biologything
acid	other-biologything
is	O
a	O
substrate	O
of	O
dihydrofolate	other-biologything
reductase	other-biologything
,	O
an	O
enzyme	other-biologything
involved	O
in	O
making	O
nucleotides	other-biologything
that	O
is	O
potently	O
inhibited	O
by	O
methotrexate	other-biologything
.	O

The	O
mutation	O
rate	O
for	O
nuclear	other-biologything
DNA	other-biologything
is	O
less	O
than	O
0.3	O
%	O
while	O
that	O
of	O
mitochondrial	other-biologything
DNA	other-biologything
is	O
generally	O
higher	O
.	O

The	O
olfactory	O
bulb	O
was	O
then	O
assessed	O
for	O
the	O
expression	O
of	O
GFAP	other-biologything
mRNA	other-biologything
-	O
a	O
common	O
marker	O
for	O
the	O
glial	O
scar	O
.	O

It	O
explains	O
why	O
nature	O
chose	O
the	O
genetic	O
code	O
with	O
``	O
only	O
''	O
20	O
canonical	other-biologything
amino	other-biologything
acids	other-biologything
for	O
ribosomal	other-biologything
protein	other-biologything
synthesis	O
.	O

The	O
genus	O
``	O
Dinotopterus	other-biologything
``	O
is	O
currently	O
considered	O
monotypic	O
,	O
but	O
formerly	O
included	O
several	O
Lake	O
Malawi	O
species	O
that	O
now	O
are	O
placed	O
in	O
``	O
Bathyclarias	other-biologything
``	O
.	O

Upon	O
ensuing	O
death	other-biologything
domain	other-biologything
(	O
DD	other-biologything
)	O
aggregation	O
,	O
the	O
receptor	other-biologything
complex	other-biologything
is	O
internalized	O
via	O
the	O
cellular	other-biologything
endosomal	other-biologything
machinery	other-biologything
.	O

There	O
is	O
still	O
ongoing	O
research	O
to	O
determine	O
the	O
reason	O
for	O
the	O
lowering	O
of	O
platelet	other-biologything
count	O
in	O
women	O
with	O
a	O
normal	O
pregnancy	O
.	O

Inhibition	O
of	O
Grb2	other-biologything
function	O
impairs	O
developmental	O
processes	O
in	O
various	O
organisms	O
and	O
blocks	O
transformation	O
and	O
proliferation	O
of	O
various	O
cell	O
types	O
.	O

Since	O
chyle	other-biologything
is	O
formed	O
from	O
these	O
acids	O
,	O
chyle	other-biologything
formation	O
will	O
reduce	O
,	O
allowing	O
the	O
defects	O
to	O
heal	O
spontaneously	O
.	O

Super-antigens	other-biologything
such	O
as	O
enterotoxins	other-biologything
activate	O
host	O
immune	O
cells	O
causing	O
T	other-biologything
cell	other-biologything
proliferation	O
and	O
cytokine	other-biologything
release	O
.	O

Monoubiquitinated	O
PCNA	other-biologything
recruits	O
polymerases	O
that	O
can	O
carry	O
out	O
DNA	other-biologything
synthesis	O
with	O
damaged	O
DNA	other-biologything
;	O
but	O
this	O
is	O
very	O
error-prone	O
,	O
possibly	O
resulting	O
in	O
the	O
synthesis	O
of	O
mutated	O
DNA	other-biologything
.	O

It	O
is	O
mainly	O
granivorous	O
,	O
but	O
will	O
occasionally	O
eat	O
insects	O
,	O
which	O
are	O
also	O
fed	O
to	O
its	O
young	O
to	O
provide	O
protein	other-biologything
.	O

Y-chromosomal	other-biologything
Adam	other-biologything
(	O
90000	O
-	O
60000	O
BP	O
,	O
dated	O
data	O
)	O
was	O
initially	O
dated	O
here	O
.	O

Similarly	O
,	O
the	O
absence	O
of	O
a	O
normal	O
fibronectin	other-biologything
matrix	O
in	O
developing	O
amphibians	O
causes	O
defects	O
in	O
mesodermal	O
patterning	O
and	O
inhibits	O
gastrulation	O
.	O

However	O
,	O
a	O
larger	O
series	O
of	O
12	O
cases	O
revealed	O
no	O
p53	other-biologything
gene	O
mutations	O
.	O

miR-181a	other-biologything
,	O
miR-181b	other-biologything
,	O
miR-181c	other-biologything
and	O
miR-181d	other-biologything
are	O
activated	O
by	O
the	O
human	O
gene	O
ERBB2	other-biologything
,	O
located	O
on	O
the	O
chromosome	other-biologything
17	other-biologything
.	O

Made	O
available	O
through	O
recombinant	O
DNA	other-biologything
technology	O
,	O
they	O
hold	O
tremendous	O
potential	O
for	O
medical	O
uses	O
when	O
a	O
person	O
's	O
natural	O
ability	O
to	O
form	O
blood	O
cells	O
is	O
diminished	O
or	O
defective	O
.	O